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Effect of Sinigrin and a Low Iodine Diet on Serum Iodine and Thyroid Hormone 
Concentrations in Non-pregnant Mares and Serum, Colostrum and Milk Iodine 
Concentrations in Postpartum Mares and Foals  
  
Adequate levels of thyroid hormones and iodine are essential for health and normal fetal 
development. Disruptions in maternal iodine metabolism during pregnancy or transfer of iodine 
to the fetus may cause fetal thyroid dysfunction, which may lead to severe negative effects on 
development and organ maturation. A syndrome characterized by prolonged gestational length, 
moderate to severe musculoskeletal deformities such as contracted tendons, failure of tarsal 
and/or carpal ossification, prognathia, signs of dysmaturity and goiter called congenital 
hypothyroidism dysmaturity syndrome in foals (CHDS) has been described. The risk factors for 
CHDS include a lack of trace mineral supplementation and consumption of Brassicaceae family 
plants containing glucosinolates (GSL) during pregnancy. Glucosinolates have negative effects 
on thyroid function and animal health in other species. There are no previous reports on the 
effects of GSL on thyroid function and iodine levels in horses at any age and physiologic state. 
There is also a lack of robust information on iodine levels in mares and foals in different body 
fluids and secretions despite the prevalence of CHDS in foals in Western Canada, where 
Brassica family GSL plants are widely cultivated, mustard family GSL containing weeds are 
abundant and soil iodine concentrations are inadequate.   
We hypothesized that the combination of a low iodine and a glucosinolate (GSL) 
(sinigrin) containing diet fed for 3 months to non-pregnant mares would affect thyroid hormones 
and serum iodine concentrations in non-pregnant mares and that colostrum, milk and serum 
iodine levels and thyroid hormone concentrations would decrease over time in healthy post-
partum mares and foals.  
Nineteen mares aged 2 to 14 years were divided into Control with iodine supplementation 
and, Low (20 mmol/day) and High GSL (35 mmol/day) diet groups without iodine 
supplementation. Thyrotropin releasing hormone (TRH) stimulation tests and serum iodine 




(TT4) and thyroid stimulating hormone (TSH) concentrations at baseline and in post-TRH 
samples were measured. The post-TRH fold changes (FC) were calculated for TSH, TT3 and 
TT4. There was a group and group by week interaction (P <0.001) in TT4 FC values, with week 
12 Control concentrations higher (P < 0.006) than all groups. Iodine concentrations decreased (P 
< 0.002) in GSL mares. 
Additionally, colostrum, milk and blood samples from ten draft mares and foals, with an 
estimated intake of 39 mg iodine per day per mare during pregnancy were obtained at foaling 
date and 10 days later. Measurements included: mare basal concentrations of serum: TT3, TT4, 
iodine; iodine in colostrum at day 0 and milk iodine (day 10); foal basal TT3, TT4 and serum 
iodine (day 0 and 10). Median ± SE foal serum iodine (268.5 ± 7.6 µg/L), TT4 (1225 ± 47.8 
nmol/L) and TT3 (14.2 ± 1.1 nmol/L) at foaling date were higher than at 10 days (70 ± 3.6 µg/L; 
69.6. ± 20.4 nmol/L; 5.4 ± 0.3 nmol/L, respectively). Colostrum iodine levels (165 ± 15.1 µg/L) 
were higher than milk (48 ± 5.6 µg/L) levels.  
In conclusion, the effect of sinigrin along with a low iodine supplemented diet did not 
have a negative impact on body weight and overall health in non-pregnant mares, but T4 
responsiveness and iodine levels decrease after 12 weeks. Similar controlled studies on the 
effects of GSL should be performed in pregnant mares in which thyroid function and adequate 
levels of iodine are more critical for the developing fetus. Furthermore, nutritional studies with 
known and confirmed iodine intakes should be performed to determine robust reference ranges 
for iodine levels in serum, colostrum and milk from mare and foal pairs at different ages. 
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CHAPTER 1: HYPOTHESES AND OBJECTIVES 
 
 
Null Hypotheses and Objectives  
Experiment 1: Feeding a non-iodine supplemented diet and the glucosinolate (GSL) sinigrin for 
12 weeks has no effect on serum iodine and thyroid hormone levels in non-pregnant mares.   
Objectives: 
1) To determine the effect of feeding a non-iodine supplemented diet and sinigrin on total 
thyroxine (TT4), total tri-iodothyronine (TT3), and thyroid stimulating hormone (TSH) 
levels at 0 and 12 weeks later 
2) To determine the effect of feeding a non-iodine supplemented diet and sinigrin on the 
response to thyroid releasing hormone (TRH) at 0 and 12 weeks later 
3) To determine the effect of feeding a non-iodine supplemented diet on serum iodine 
concentrations in non-pregnant mares at 0 and 12 weeks later  
 
Experiment 2: Serum, milk and colostrum iodine levels from healthy post-partum mares are 
unrelated to their foals thyroid hormone concentrations and serum iodine levels in the first 10 
days post foaling. The equine mammary gland does not concentrate iodine for the newborn foal.  
Objectives: 
1) To determine the level of iodine in mares’ serum, milk and colostrum following a 
healthy pregnancy   
2) To determine the level of foals’ serum iodine in relation to TT4 and TT3 concentrations 
at foaling day and 10 days later following a healthy pregnancy  
3) To determine if there is a relationship between iodine levels in mare’s colostrum and 











CHAPTER 2: LITERATURE REVIEW  
 
2.1 Introduction   
It has been demonstrated that healthy thyroid function is essential for metabolism, and 
reproduction; and impacts seasonal reproductive activity, estrus cyclicity, fetal programming and 
fetal development in horses [1–3]. Thyroid function, because of its central role in fetal 
development, post-natal growth and metabolism affects the future performance of horses [1]. The 
prevalence and impact of thyroid dysfunction in the equine population has not been properly 
assessed and there are still many knowledge gaps [4]. There are a few studies that have examined 
the impacts of environmental factors such as toxic weeds, low environmental iodine and excess 
nitrates on pregnancy outcomes in mares [5–9]. Early pregnancy loss, abortion, goitre and 
musculoskeletal defects have been reported in association with these exposures. Recently 
Swerczek and Dorton (2019) published information that implicated high nitrate levels as a cause 
of neonatal thyroid dysfunction, limb contracture and mare reproductive loss syndrome (MRLS) 
in Kentucky [9]. 
The experiments in this thesis address areas where there is little information, such as the 
impact of glucosinolates (GSL) on thyroid function in non-pregnant mares and a description of 
serum, colostrum and milk iodine levels in post-partum mares in relationship to thyroid hormone 
levels. In preparation for this research, a general review of equine: thyroid anatomy, physiology, 
role of iodine in thyroid function, assessment of thyroid function and dietary factors affecting 
thyroid function in non-pregnant mares, pregnant mares, and foals; and the role of thyroid 
hormones and iodine metabolism in fetal growth, maturation, and during the post-partum period 
was performed. Furthermore, a review of the principal nutritional factors influencing thyroid 
function in horses, such as GSL, and their effects on serum iodine and thyroid hormone levels in 
non-pregnant mares compared to other domestic species was performed. 
 
2.2  Anatomy  
During fetal development, the two principal embryonic structures involved in thyroid 




larynx and is responsible for the follicular cell development; and the ultimobranchial body, 
which gives rise to the calcitonin cells and originates from the fourth pharyngeal pouch [10]. 
Furthermore, the pre-colloid, colloid and follicular stages of the thyroid gland development are 
essential for growth and early maturation of the fetal thyroid gland, resulting in the functional 
development of the fetal hypothalamic-pituitary-thyroid (HPT) axis, which is capable of 
secreting thyroid hormones when the follicular stage is fully developed [11].  
In the adult horse, the thyroid gland is located in the dorsolateral aspect of the third to 
sixth tracheal rings and consists of two lobes that are connected by an isthmus of fibrous tissue. 
It has been reported to have a normal mean (range) weight of 0.08 g/kg (0.01 – 0.15 g/kg) for 
adult horses and 0.28 g/kg (0.12 – 0.67 g/kg) for foals, based on grams of thyroid tissue per 
kilogram of body weight calculation[12]. The weight and size of the thyroid gland was also 
reported by Schotthauer (1931) who reported that the thyroid weighed about 23 grams (g) for 
adult horses with a mean weight of 0.04 g/kg and a range of 0.02 -0.06 gm/kg. Thyroids greater 
than 0.066 g/kg were histologically abnormal [13]. The dimension of the thyroid lobes measured 
using transcutaneous ultrasound were: length 3.6 – 3.9 cm, width 1.9 – 2.1 cm and height 1.6 - 
1.7 cm [14,15]. 
The vascular supply enters the thyroid lobe at the cranial pole with the cranial thyroid 
artery from the external carotid and at the caudal pole with the caudal thyroid artery from the 
subclavian artery, respectively [16]. The gland is not easily visible nor palpated in the healthy 
young horse; however, in horses with thyroid gland tumors or goiter these may be palpated as a 
firm and movable structure of variable size [10]. Histologically, the thyroid gland is surrounded 
by a capsule of connective tissue and divided into lobules; each lobule contains multiple follicles 
filled with colloid. The appearance of the follicular cells changes according to the thyroid gland  
activity, and ranges from low cuboidal cells in the resting stage to cuboidal or columnar cells 
with vacuoles in the active stage [17]. The thyroid follicle is considered to be the functional unit 
of the thyroid gland, whereas, the colloid contains an essential protein for thyroid hormone 
synthesis and storage, called thyroglobulin [18]. In addition, the thyroid gland also contains 







2.3 Physiology of the equine thyroid gland 
2.3.1  General physiology 
 
Thyroid hormone synthesis involves two major actions, entry of iodide (I-) to the thyroid 
and into follicular cells through the sodium / iodide (Na+/I-) symporter, where I- is oxidized into 
iodine by the thyroid peroxidase enzyme. Thyroglobulin, a glycoprotein containing multiple 
tyrosine residues, is synthesized in the follicular epithelial cells, and secreted into the follicular 
lumen where it is stored as colloid. Once in the follicular lumen, iodine binds to carbon position 
3 or 5 of multiple tyrosine residues present in the thyroglobulin to form monoiodotyrosine (MIT) 
and diiodotyrosine (DIT), which are then coupled by the enzyme thyroid peroxidase to form 
thyroxine (T4) and triiodothyronine (T3). Both TT3 and TT4 are stored in the follicular lumen 
with the remaining thyroglobulin, and the MIT and DIT residues that did not couple [18,19]. 
Secretion of thyroid hormones into circulation involves endocytosis and degradation of the 
colloid containing the thyroglobulin followed by the release of greater amounts of T4. Despite 
higher concentrations of T4 in plasma, T3 is the biologically active hormone. Triiodothyronine’s 
binding capacity to the thyroid hormone receptor in target tissues is reported to be 15-fold higher 
than T4, and T3 is not highly coupled to plasma proteins compared to T4. However, T4 has a 
lower metabolic clearance rate with a half-life of approximately 7 days compared to the one-day 
half-life of T3. The ability of T4 to bind to plasma proteins such as thyroxine binding globulin,  
serves as a circulating reserve to ensure adequate deliver of T3 to target tissues based on their 
metabolic rate [18,20]. Before thyroid hormones (THs) are released into circulation, a specific 
amount of T4 undergoes local deiodination to form T3 in the thyroid, this serves as a recycling 
mechanism of iodine for further involvement in the new synthesis of thyroid hormone, whereas 
the majority of the circulating T3 is produced by the deiodination of T4 in peripheral tissues. The 
process consists of removal of iodine from carbon 5 of the T4 outer ring and is regulated by the 
action of deiodinases type I, II and III (D1, D2 and D3) [18]. The D1 enzyme is found mainly in 
the liver, kidney and thyroid gland, and is involved in the production of the majority of the 
circulating T3. Similarly, D2 is expressed mainly in the brain, pituitary gland, adipose tissue and 
thyroid gland; it is responsible for controlling intracellular T3 concentrations and protects the 
tissues from the negative effects of low thyroid hormone concentrations for a long period of time 




detrimental effects, such as the brain. In contrast, D3 is responsible for inactivation of T4 by 
converting it to reverse T3 (rT3). The D3 is predominantly found in brain, placenta and skin, and 
plays a key role in placental protection of the fetus against exposure to high levels of maternal 
thyroid hormones [18,20,21]. 
It is worth mentioning that thyroid hormone bioavailability not only depends on the 
expression and activity of transporters, but also on the expression of intracellular THs receptors 
in the target tissues. Thyroid hormone receptors belong to the ligand dependent transcription 
factor superfamily. Thyroid receptor alpha (TRa) and thyroid hormone receptor beta (TRb) are 
the two isoforms reported to be expressed in the fetus by mid-gestation [11]. TRa is expressed in 
almost all the tissues, but their effects have been studied more in the liver, bone, fat, brain and 
heart. The different expressions of both isoforms are well investigated in the developing brain. In 
rats, TRa is highly expressed in the brain during fetal development, whereas TRb is highly 
expressed in the brain in the postnatal development [22]. In addition, TRa expression is highly 
dominant in the cardiovascular system. Binding of thyroid hormone increases heart rate and 
cardiac output [22]. In domestic animals, there are species specific expressions between the two 
isoforms. For example, in fetal pigs, TRb is highly expressed in heart and skeletal muscles at 
birth, whereas TRa expression decreases [11].  
The HPT axis controls and regulates the synthesis and release of T4 and T3 through a 
negative feedback mechanism. Thyrotropin releasing hormone (TRH) is synthesized by the 
hypothalamic paraventricular nucleus and is transported to the adenohypophysis through the 
capillary plexus, where it binds to receptors on adenohypophyseal cells called thyrotrophs. 
Thyrotrophs then release thyroid-stimulating-hormone (TSH), also referred to as thyrotropin, 
into the systemic circulation [20]. The TSH is transported to the thyroid gland and binds to TSH 
receptors located in thyroid follicular epithelial cells, and acts to stimulate iodine uptake and 
thyroid hormone synthesis. It is worth mentioning that growth and function of the thyroid gland 
is highly stimulated by the intracellular signals caused by TSH, such as the rise in cyclic 3’, 5’- 
adenosine monophosphate (cAMP), for that reason a persistent increase in circulating TSH levels 
above the normal range will result in marked thyroid hyperplasia [18,20]. The negative feedback 
is based on the local production of T3, which acts directly on thyroid hormone receptors and 




For that reason, elevated thyroid hormone concentrations in blood inhibit TSH secretion, 
whereas low levels of thyroid hormone enhance the release of TSH [18,21].  
 
 
2.3.2  Effect of age, sex and geographic location  
 
The fetal hypothalamic-pituitary-adrenal (HPA) axis undergoes developmental changes 
that leads to the final secretion of cortisol. Little is known regarding the effects of cortisol on 
equine thyroid hormone levels during the last 48 to 72 hrs of pregnancy in the mare; however, 
the prepartum increase of fetal cortisol seen in sheep causes an abrupt increase in circulating T3 
by an increase in T4 deiodination. In addition, high T3 concentrations are believed to be 
dependent of the proper maturation of the HPA axis [23]. In the neonatal period, thermogenesis, 
adequate pulmonary exchange, hepatic gluconeogenesis and post-natal maturation of vital organs 
and systems are essential for neonatal survival and adequate adaptation [11]. Levels of TT4 and 
TT3 are approximately 14 times higher in the healthy neonatal foal compared to adult horses.  
High rates of peripheral conversion of T4 to T3 have been reported. High thyroid hormone levels 
coincide with a high metabolic demand in the neonatal period followed by a dramatic decrease in 
the first week of life and then a gradual decline over the next months of life until thyroid 
hormones levels are similar to the adult levels [11,24].   
In contrast, resting T4 levels decrease, whereas TSH levels increase as the horse ages, 
similar to what has been reported in elderly humans and dogs. It is still uncertain whether the 
increase in circulating levels of TSH noted in older horses indicates that subclinical 
hypothyroidism is present as a consequence of a higher proportion of older horses having 
abnormal thyroid tissue, or is a normal hormonal change in the aged horse [25]. Other factors 
such as gender and weaning have been reported to have a direct effect on thyroid hormone levels 
in the growing foal. Fazio et al. (2007) reported an abrupt decrease in TT3 levels without 
significant changes in TT4 around the time of weaning suggesting the ability of the thyroid gland 
to adapt to different physiological processes in the first year of life [26]. Furthermore, growing 
colts had higher basal TT4 levels around weaning time (5 months) and 13 months of life, with a 
positive correlation between basal T3, body weight ( r = 0.240; P < 0.02) and age (r = 0.281; P = 




The ability of the horse to adapt to endemic goiter areas has been partially assessed in 
North-eastern Sicily, Italy, where severe iodine deficiency disorders have been reported in 
humans, including thyroid dysfunction. There were no significant differences in resting THs 
levels between horses managed in endemic goiter areas versus non-endemic areas. There were 
only significant differences between male and female groups, and it was concluded that there 
was a physiological adaptation response to the low iodine environment, as there were no signs of 
hypothyroidism in horses compared to what was reported in humans exposed to iodine deficient 
environments. Nevertheless, TSH levels were not measured in all horses, thus, complete thyroid 
function was not fully assessed [27].  
 
2.3.3 Thyroid function in pregnant vs non-pregnant mares 
 
In all mammalian species, metabolic and hormonal changes during pregnancy have a 
direct effect on maternal thyroid hormone synthesis. Maternal HPT axis maintains adequate 
levels of THs based on metabolic and energy demands from the dam and the growing conceptus. 
In women, the human chorionic gonadotropin (hCG) secreted during the first trimester of 
pregnancy is not only essential for maintenance of pregnancy, but also has thyrotropic effects.  
The alpha subunit of TSH is reported to be structurally similar to hCG, which induces an abrupt 
increase in circulating free T4 (fT4) and free triiodothyronine (fT3). TSH levels are commonly 
low due to the negative feedback caused by high THs levels [28]. It has been demonstrated in 
humans, and speculated in domestic animals that during the first trimester of pregnancy, the fetus 
relies entirely on maternal THs due to the inability of the fetal HPT axis to synthesize THs [29]. 
Thus, maternal THs play a key role in early embryonic growth and development. In addition, an 
increase in circulating TT4 and TT3 is accompanied by an enlargement of maternal thyroid gland 
of approximately 18% and an increase of 50% in TH production, demonstrating a high degree of 
thyroid gland activity in pregnant women [28]. In contrast, Fazio et al (2016) reported no 
significant differences in serum TT4 and TT3 between pregnant and non-pregnant mares over a 
12-month period. Nevertheless, higher TT3 circulating levels were observed on the second 
month of pregnancy, and the lowest in the 11th month, whereas, TT4 circulating levels were 
higher in the 5th month and decrease by the 11th month [30]. Similarly, TT3 has been reported to 
change over time during the first 12 weeks of pregnancy, with no effect on TT4. Higher TT3 




mares, which also coincides with an increase in equine chorionic gonadotropin (eCG) secretion 
by the endometrial cups, indicating that there is an effect of pregnancy on thyroid hormone and 
also a period of high synthesis and release of maternal THs during early pregnancy [31,32]. 
 
2.3.4 Thyroid hormone values in non-pregnant mares and foals.  
 
Reference ranges from the Animal Health Diagnostic Center at Cornell University, were 
used for the present study. These values were based on samples obtained from healthy horses.  
Adult reference ranges are: 
• T3:  0.408 – 1.088 nmol/L 
• T4: 12.87 nmol/L – 38.6 nmol/L 
• fT4: 15.45 pmol/L - 23.17 pmol/L  
 
Foal reference ranges in the first 14 days of age are reported in Table 2.1, showing the dramatic   
decrease in THs concentrations after 7 days post-foaling. 
 
Table 2.1 Mean (range) of serum levels of total thyroxine (TT4 nmol/L) and triiodothyronine (TT3 
nmol/L in foals from foaling date (day 0) to 14 days post-foaling (Animal Health Diagnostic 
Center- Cornell) 
Age 
(Days) T4 nmol/L T3 nmol/L 
0 
392.5 
(339.2 - 445.7)  
6.6 
(4.4 - 8.7) 
1 
319.2 
(275.0 - 363.3) 
3.395 
(1.2 - 5.6) 
2 
348.1 
(237.6 - 448.3) 
11.6 
(7.0 - 16.7) 
3 
276.2 
(228.2 - 329.3) 
11.9 
(4.7 - 17.9) 
4 
281.9 
(221.9 - 349.8) 
9.6 
(6.9 - 12.3) 
5 
187.9 
(166.1 - 217.9) 
6.3 
(3.4 - 10.5) 
6 
210.8 
(134.4 - 337.4) 
7.7 
(3.8 - 13.7) 
7 
140.8 
(77.6 - 193.2) 
6.8 






(30.9 - 62.9) 
3.2 
(2.8 - 3.4) 
14 
71.8 
(46.8 - 99.7) 
3.5 
(3.05 - 4.42) 
 
 
It is worth mentioning that there are other authors who reported normal reference ranges 
that can be useful when assessing thyroid hormone levels. Breuhaus (2018) reported serum TT4, 
TT3, and free T4 and T3 by equilibrium analysis (fT4D, fT3D), and TSH levels in 24 to 36-hour 
neonatal healthy foals, and young (3 - 6 years and 7 – 10 years), middle aged (11 – 14 years) and 
old horses (≥ 15 and ≥ 20 years). The most relevant information is the decrease in TT4 
concentrations as the horses age compared to younger animals. The hormone values are shown in 
Table 2.2 [24,25]. 
 
Table 2.2. Median ± 95% confidence interval and range of serum levels of total thyroxine (TT4 
nmol/L), free thyroxine (fT4 pmol/L), total triiodothyronine (TT3 nmol/L), free triiodothyronine 
(fT3 pmol/L) and TSH (ng/mL) in foals, and young, middle age and old horses. 
Age  n TT4 nmol/L fT4D pmol/L TT3 nmol/L fT3 pmol/L TSH ng/ml 
24. – 36 hrs 20 260.5 ± 16.9  
(191 – 318) 
97.5 ± 13.6  
(49 – 144) 
8.2 ± 0.8  
(6 – 11.8) 
10 ± 2.  
(5.6 – 24.2) 
0.24 ± 0.07  
(0.10 – 0.68) 
3 - 6 yrs 15 24 ± 5.8  
(8 – 44) 
23 ± 4.4  
(9 – 40) 
1.2 ± 0.22  
(0.6 – 2.0) 
1.7 ± 0.5  
(1.2 – 4.2) 
0.3 ± 0.08  
(0.03 – 0.42) 
7 – 10 yrs 27 18 ± 3.6  
(6 – 46) 
19 ± 3.7  
(9 – 47) 
0.8 ± 0.22  
(0.4 – 2.9) 
1.5 ± 0.5  
(0.5 – 5.7) 
0.4 ± 0.08  
(0.06 – 0.80) 
11 – 14 yrs 13 19 ± 4.3 
(8 – 32) 
16 ± 7.0 
(7 – 40) 
0.9 ± 0.23  
(0.4 – 1.6) 
1.3 ± 0.8  
(0.8 – 4.5) 
0.3 ± 0.09  
(0.03 – 0.5) 
≥ 15 yrs 16 15 ± 4.5 
(6 – 32) 
24 ± 3.2 
(11 – 33) 
0.9 ± 0.2  
(0.3 – 1.8) 
2.05 ± 0.8  
(0.1 – 5.9) 
0.4 ± 0.13  
(0.1 – 0.97) 
≥ 20 yrs 10 14.5 ± 6.8 
(6 – 32) 
23.5 ± 4.4 
(11 – 32) 
0.95 ± 0.2  
(0.4 – 1.4) 
2.05 ± 1.15  
(0.1 – 5.9) 
0.5 ± 0.2  





2.3.5 Effect of seasonality 
  
The link between thyroid hormone levels, seasonality and temperature have been studied 
in many domestic animals whose reproductive performance relies solely on the photoperiod and 
the availability of the feed under natural circumstances, like the horse and small ruminants. 
Hormonal levels, energy utilization and metabolic rate tends to be different in a seasonal animal 
versus a non-seasonal animal, hence, thyroid hormone levels may have variations during the year. 
It is not clear if there are interactions between seasonality and ambient temperature in horses and 
what those effects might be on thyroid hormone levels. Johnson (1986) reported higher serum TT4 
levels between October and November, with a very slight negative correlation with photoperiod; 
higher prolactin concentrations from May to August were found with lower levels from September 
to February, whereas higher TT3 levels were found to be in December through May and lower 
levels from July to October. Mares in the previous study were exposed to ambient photoperiod 
consisting of 8 hours light and 16 hours dark in the winter period. The study results showed that 
prolactin levels were positively correlated with photoperiod. Prolactin was lower in winter months 
and inversely related to THs concentration. There was an increase in TT4 and TT3 during the 
winter months, suggesting an increase in metabolic rate around this time; TT3 was reported to be 
inversely correlated with temperature suggesting that lower temperatures in winter enhances an 
increase in circulating TT3 [33]. The relationship of THs levels and season has also been reported 
in goats. A study conducted in Nigeria, where TT3 and TT4 levels were measured in cold-dry and 
hot dry weather, revealed an increase in THs levels during the cold dry months demonstrating an 
increase in metabolic rate along with an increase in heat generation to promote optimal body 
temperature during low ambient temperature, similar to what it has been reported in other species 
such as goats [34]. On the contrary, Fazio et al (2018) reported higher T3 levels in May and June 
and the lowest in February, whereas T4 levels were higher in July to August and lower in February 
to March in mares housed in breeding farms near Catania, Sicily. It is probable that the differences 
reported in Fazio’s study could be due to the geographic area and the temperature during summer 
and winter months [30]. Critical studies in this regard concerning seasonal and temperature need 






2.4  Role of iodide in thyroid function  
2.4.1 Iodide metabolism in the mare  
 
There are few studies on iodine metabolism in the horse, and it has been assumed that it is 
similar to what has been reported in humans. There are two main sources of iodine: plants grown 
on iodine-rich soil and seawater, seaweed or alga phytoplankton which have also been reported to 
be a source of iodine in Asian countries. It has been reported that grass forage provides 
approximately 0.2 – 0.3 mg I- per kg of dry matter (DM) [35]. After ingestion, iodide is 100% 
bioavailable and is fully absorbed in the small intestine, mainly in the duodenum. Once in the 
bloodstream, I- metabolism involves three steps: the first step starts with the uptake of I- from 
bloodstream into the follicular cell of the thyroid gland. This process is accomplished by an active 
transport system through the sodium/iodide symporter protein (NIS) found in the follicular cell, it 
is Na+-K+ pump dependant and its activity is regulated by TSH signaling and circulating iodine 
levels. It is worth mentioning that the NIS has the capacity to raise intrathyroidal levels of iodide 
20-50-fold higher than in general circulation. The NIS is also present in mammary gland tissue, 
salivary glands, gastric and intestinal mucosae. Furthermore, I- transport through this symporter 
can be substituted by other substances such as perchlorate, nitrate, thiocyanate and pertechnetate 
causing a decrease in I- uptake by the thyroid gland [36]. In humans, it has been demonstrating 
that NIS in the lactating mammary gland provides an important supply of iodine to the newborn 
[36]. The second step involves the synthesis and secretion of thyroglobulin, previously discussed. 
The third step involves  I- oxidation by the thyroid peroxidase (TPO) enzyme, in which the iodide 
is moved to the follicular lumen to be oxidized to iodine, followed by the organification of the 
thyroglobulin, which includes iodination of the tyrosine residues to form MIT and DIT followed 
by T4 hormone synthesis [37,38].  
Iodine released by deiodination of T4 can be reused for further thyroid hormone synthesis 
or it can be excreted mainly through urine. In humans, approximately 90% of the I- is excreted 
through the kidneys. Iodine excretion has been correlated with iodide intake, a small amount of 
iodide has been reported to be excreted through feces and sweat [38]. In horses, renal excretion is 
highly associated to I- intake, indeed, measurement of creatinine:iodine ratio has been reported to 
be a sensitive method to assess I- intake, whereas, fecal excretion has not been associated with 





2.4.2  Iodine metabolism in the foal  
 
Iodide metabolism in the foal is believed to be similar compared to the adult horse. 
Nevertheless, renal maturation in the neonatal foal is not fully accomplished until at least 4 weeks 
after birth. Regardless of having the maximum number of nephrons before birth, there is still a 
significant increase in glomerular volume during the first months after foaling, suggesting that 
adequate glomerular filtration is not completely achieved in the neonatal period, as seen in the 
sheep and rat [39]. Thus, the equine neonate has physiologic similarities to what has been reported 
in neonatal calves, where there is a lack of an efficient excretion route for iodine, predisposing to 
thyroid dysfunction due to iodine excess [40].  
 
2.4.3 Reference range in equine serum and milk 
 
Serum iodine references ranges in adult horses are based on Puls [41]  and are as follows: 
Deficient = < 10 µg/L; Marginal = 11 - 20 µg/L; Adequate = 20 - 49 µg/L and High = > 50 µg/L. 
Milk iodine reference ranges in mares based on Puls [41] are: Deficient: < 4 µg/L; Adequate: 10 -
16 µg/L; and Toxic: 50 µg/L.  
 
2.4.4 Iodide requirements in mares and foals  
 
There is a lack of robust information on I- requirements in adult horses and foals, and some 
values have been adapted from other species. An intake of 3 – 5 µg/kg body weight (BW) I- per 
day for adult horses is required for maintenance, and during exercise 5 µg/kg /BW I- per day, with 
a maximum intake of 10 µg/kg /BW I- for broodmares and foals has been recommended [35]. It is 
worth mentioning that iodine requirement in the last trimester of pregnancy is higher due to the 
exponential growth and maturation that the fetus undergoes.  
2.4.5 Comparative Iodine levels in serum and milk among species  
 
Iodine levels have been reported in mare’s milk to range from 4 – 450 µg/L in healthy mares 




Silva et al (1987) reported milk levels from mares that had been fed an excessive quantity of 
iodide in pregnancy (350 mg daily) that resulted in abortion, fetal and neonatal goitres. The 
mares fed the excess iodine had milk iodine levels that averaged 473 µg/L and had values 
ranging from 175 - 1,380 µg/L, and a group of healthy mares were reported to have average milk 
iodine levels of 124 µg/L ranging from 30 – 450 µg/L [42].   
Mochizuki reported serum iodine ranging from 17.5 – 29.3 µg/L. Serum iodine in the mares 
fed a seaweed supplement containing excessive amounts of iodine averaged 338 µg/L (range 20 
– 70) and healthy mares averaged 39 µg/L  (range 30 – 57.5) [8,44]. 
 
Table 2.3. Serum reference ranges (µg/L) in serum, colostrum and milk samples among other 
domestic species. Literature references for these iodine values are shown in square brackets.  
 
Species I serum µg/L I colostrum µg/L I milk µg/L 
Horse 20 – 49 [41] unknown 4 – 124 [41–43,45] 
Donkey 12.9 – 38.7 [46,47] unknown 7, 12.8 - 231.9 
[46,47] 
Cow 99 – 175 [48,49] 87[48] 100 – 900 
[43,47,49] 
Goat 5.4 – 36.6  [49] unknown 60 - 130, 575 [49] 
Sheep 27, 60-100 [50,51] 57, 2083 [50] 1423 [49],  
192 [43,47,50] 
Human 65-164 [52] 21 –304 [36] 62l [53] 
 
2.5  Thyroid function and iodine during pregnancy and peripartum period  
2.5.1 Role of placenta in thyroid hormone delivery to the fetus  
 
To the author’s knowledge there is very little information regarding thyroid hormone 
delivery to the equine fetus during pregnancy in the mare. Allen and coworkers (1995) evaluated 
THs levels from equine fetuses collected at an abattoir. They showed no detectable T4 and T3 
were present until the 4 month of pregnancy, when T4 was measured at 47 nmol/L, then a steady 




a mean of 353 nmol/L and T3 2.6 nmol/L, after which levels plateaued in late pregnancy [54]. 
More research has been conducted in humans and sheep on the role of placenta in thyroid hormone 
delivery to the fetus. It is well documented that placental transfer of thyroid hormones from 
maternal to fetal circulation is quite variable among domestic species, and this difference relies on 
the type of placentation. The hemochorial placenta found in humans, dogs and cats are reported to 
be permeable to maternal THs through the whole pregnancy, whereas the epitheliochorial placenta 
found in horses, bovine and small ruminants have been found to be impermeable to THs at least 
from the second half of pregnancy [11]. In addition, it has been proposed that thyroid hormone 
delivery to the fetus before the complete maturation of the fetal HPT axis in species with 
epitheliochorial placenta, approximately before the 5th or 6th week of gestation in the sheep, is 
through maternal transfer of TRH to the fetus as the placenta can be permeable to TRH [21]. The 
placenta not only regulates the delivery of thyroid hormones from the dam to the fetus, but along 
with fetal liver, kidneys and thyroid gland it also maintains adequate levels of THs in fetal 
circulation at every stage of gestation.  
Factors such as iodothyronine deiodinases, sulfotransferases, sulfatases for metabolism of 
THs, thyroid hormone transporters and thyroid hormone binding to proteins in the trophoblast cells 
have been reported to modulate the process, in which only the expression of D3 and sulfation of 
THs have been demonstrated in domestic animals [55]. In human and ovine placenta, D3 is 
reported to be highly active in the placenta, it metabolizes the majority of maternal T4 to the 
inactive rT3 and limits its exposure to the fetus, also it has been suggested that D3 contributes to 
the release of iodine into fetal circulation for fetal thyroid hormone synthesis [11,55], for that 
reason, high levels of T4 and rT3 along with low levels of T3 compared to the postnatal life are 
reported in both human and ovine fetuses. Furthermore, it has been reported that approximately 
80% of the T4 is metabolized to biologically inactive sulfated forms through sulfotransferases in 
fetal liver, kidneys and brain. It is worth mentioning that sulfated forms can be converted back to 
T3 by sulfatase enzymes in liver, lung, brain and placenta, suggesting an efficient mechanism 
against cases of hypothyroidism, in which a constant supply of adequate levels of T3 is important 





2.5.2 Role of placenta in iodine delivery to the fetus  
 
There are no direct studies performed in the horse on iodine uptake by the fetus; however, 
it has been demonstrated in humans and postulated in all mammalian species that the placenta 
plays a key role in the active transport of iodide from maternal to fetal circulation, which despite 
the type of placentation maternal iodide delivery to the fetus is essential for normal fetal thyroid 
hormone synthesis [11]. Diffusion of thyroid hormone may occur in early to mid – pregnancy [54]. 
In women, the presence of iodide transporters, a NIS, similar to what has seen in the mammary 
gland and thyroid gland, in the syncytiotrophoblastic cells of the human placenta have been 
demonstrated. In addition, the placenta is reported to have higher iodine levels compared to other 
tissues, suggesting the ability of the placenta to store iodide. The comparison of iodine content in 
placentas from women giving birth at term and based on iodine intake was performed to determine 
the role of the placenta on iodine storage and whether the delivery of iodide to fetal circulation is 
related to iodine content in the diet [56]. The author showed that iodine content in the placenta is 
associated with dietary iodine intake, which confirms the efficiency of the placenta to store iodide 
at least in the last trimester of pregnancy [56].  Due to the ability of the placenta to concentrate 
iodide and that can be affected by iodine intake, hypothyroidism during fetal development can be 
achieved from iodine excess due to a failure of maternal iodine excretion through urine and high 
amount of iodine exposure in utero.  
 
2.5.3 Fetal growth and maturation  
 
Maternal THs can have an indirect effect on fetal growth by altering placental 
development. Silva et al. (2018) stated that maternal THs are directly involved in proliferation, 
differentiation and endocrine functions of the trophoblastic cells due to high binging of THs to 
receptors present in the syncytiotrophoblast cells of the human placenta[21]. It has been 
documented that maternal thyroid dysfunction in the pregnant women can lead to preterm delivery, 
abortion, mental deficits in the newborn and growth retardation [21]. In addition, hypothyroidism 
can impair fetal weight at birth by affecting the vascular development and increasing the apoptotic 
rate of the placenta in rats, suggesting that alterations in placental vascular development can be 
present in hypothyroid women with spontaneous abortion and pre-eclampsia, and adequate THs 




not been proven in horses, however, Wilsher et al. (2013) examined the placenta of eight 
Thoroughbred foals born at term with moderate to severe degrees of congenital flexural 
deformities[58]. The most common finding was a notable reduction in the allantochorion 
dimensions mostly in the body and pregnant horn, with long avillous bands on the chorionic 
surface at the base of the pregnant horn [58]. It is worth noting that six out of the eight foals had a 
history of dystocia, and four were euthanized due to the severity of the flexural deformities. More 
studies need to be performed to determine if there is a direct association between iodine deficiency 
and inadequate fetal exposure to maternal THs during the critical period of placenta and fetal 
development in the horse, which can contribute to congenital flexural deformities.  
Furthermore, adequate levels of maternal and/or fetal THs are essential for normal fetal 
growth in all mammalian species. The most remarkable example on the importance of regulatory 
effects of THs on fetal growth is reported in species with little placental transfer of maternal THs 
to fetal bloodstream, such as small ruminants and horses, in cases of fetal thyroid hormone 
deficiency. Allen et al (1998) reported the negative impact on intrauterine growth followed by 
partial fetal thyroidectomy at 215 days of gestation. The most noticeable changes were marked 
thyroid hyperplasia, signs of immaturity, severe tendon laxity, depression and lethargy, and 
inadequate carpal and tarsal bone ossification in two foals [59], suggesting that fetal thyroid 
hormones are necessary for fetal mass and cell differentiation of the musculoskeletal system during 
the second and last trimester of pregnancy in the horse. During skeletal development in utero, TSH 
acts directly in cartilage and bone formation by enhancing the expression of TSH receptor in 
chondrocytes, osteoblasts and osteoclasts. Similarly, chondrocyte differentiation and vascular 
invasion of cartilage is reported to be highly sensitive to T3, indicating that thyroid hormones are 
critical for endochondral ossification, control of chondrocyte maturation, cartilage matrix 
synthesis and linear growth [20]. Deiodinases type 2 activity have been reported to be essential for 
osteoblast function, maintenance of bone structure and strength. For that reason, it is not 
uncommon to find skeletal dysplasia such as a broad face, scoliosis, absence of ossification centers 
and congenital hip dislocation in cases of congenital hypothyroidism in infants, similar to what is 
seen in congenital hypothyroidism syndrome in neonatal foals [20]. Depending on the stage of 
pregnancy at the time of thyroidectomy and duration of thyroid hormone deficiency in fetal sheep, 
reduction of bodyweight and skeletal growth of limbs and vertebrae are common features reported 




permeability to maternal THs can diminish the negative effects of fetal THs deficiency by adequate 
maternal THs delivery to the fetus, which acts as a compensatory mechanism. Nevertheless, when 
maternal and fetal THs concentrations are reduced, severe neuromotor, auditory, skeletal and 
respiratory abnormalities can arise [11]. 
Endocrinologically, premature infants are usually low in serum T4 and T3 concentrations 
along with immaturity of several tissues and physiological systems, similar to what has seen in 
premature foals and lambs. In sheep, normal endocrinologic changes near term involves changes 
in thyroid hormone metabolism by enhancing T3 release and reduce its clearance. This process is 
achieved mainly by increasing hepatic D1 activity, which increases T4 deiodination to T3, and 
reduces the expression of D3. The rise of T3 close to term is well documented in several domestic 
species and is essential for final maturation, synthesis and release of the surfactant by type II 
pneumocytes, of cardiomyocytes by increasing its size and population along with ensuring 
activation of physiological processes essential for neonatal survival such as thermogenesis, hepatic 
glucogenesis and pulmonary exchange [11,23]. In addition, cortisol acts as an important regulator 
of several iodothyronine deiodinases during late gestation, thus, the lack of endogenous prepartum 
surge of cortisol decreases the up regulation of renal and hepatic D1 activity with no down 
regulation of  D3 activity in placenta, preventing the prepartum rise of T3 [23].  
Ten out of fourteen neonatal foals born with moderate to severe musculoskeletal 
abnormalities had low TT4 and TT3 concentrations at birth with thyroid hyperplasia in six of them, 
confirming the negative impact of THs deficiency during the final growth and maturation of the 
musculoskeletal system in the equine [60].  
 
2.5.4 Thyroid hormones and iodine in the neonatal period  
 
Cellular and metabolic changes induced by thyroid hormones have a direct impact on 
cardiac, liver and respiratory systems during the transition to extrauterine life. Activation of 
hepatic gluconeogenesis at birth are mediated by THs. The ability to maintain adequate levels of 
glucose between placental separation and onset of suckling are dependent on normal glycogen 
storage and glucogenic enzyme activities in the liver, which is activated by the prepartum rise of 




ingest colostrum. In addition, all mammalian neonatal species require an increase in heat 
production compared to in utero. Activation of the non-shivering thermogenesis at birth are 
dependent on THs, thus, the inability to maintain adequate body temperature can prevent oxygen 
consumption by the liver, brain, and adipose tissues. Furthermore, gas exchange and lung 
ventilation in the neonatal period depend on removal of lung liquid and surfactant production, and 
thyroid hormone concentrations play a key role in the process after birth [11].  
Iodine levels in the neonatal period in horses have not been fully determined; however, it 
can be postulated that due to the dramatic increase in metabolic demand that leads to an increase 
in THs synthesis and release, iodine levels will also be expected to be high in the neonatal period 
 
2.5.5 Methods for determination of iodine levels  
 
Iodine is measured using a variety of laboratory methods including: capillary 
electrophoresis, ion chromatography, high-performance liquid chromatography, gas 
chromatography, spectrophotometry, ion-selective electrode, polarography, voltammetry, atomic 
emission spectrometry, and neutron activation analysis. Measurement of iodine in serum, urine 
and milk is accomplished mainly by two methods. The kinetic spectrophotometric method is called 
“Sandell-Kolthoff reaction”. It has been successfully applied to determine protein bound and total 
inorganic serum iodine, urinary iodide, food, feces and amniotic fluid. However, high 
concentrations of thiocyanate, some trace metal ions like silver or mercury, and nitrite, ascorbic 
acid and iron interfere with the reaction, which decreases its sensitivity in cases when exposure to 
nitrites or GSL has occurred [61,62]. Another method is inductively coupled mass spectrometry 
(ICP-MS) which is a highly sensitive method. This occurs by ionizing the sample with coupled 
plasma followed by separation and quantification of the ions by a mass spectrometer, even though 
it is not the best test to measure iodine, the sensitivity is higher compared to the rest of the methods 
[61]. Iodine content in urine and milk are commonly analyzed worldwide for nutritional and 
epidemiological studies in humans. A modified protocol based on alkaline ashing prior to final 
determination for iodine by the Sandell and Kolthoff method increased the sensitivity of this test 
by removing the organic matter that can interfere with the result [43]. Iodine is also quantified 
indirectly by measurement of thyroid hormones as the thyroid hormones are the main organic form 




2.6  Nutritional factors influencing thyroid function  
Important nutritional factors associated with thyroid function includes minerals and 
vitamins such as iodine, selenium, zinc, copper iron and vitamin A;  exposure to plants containing 
goitrogens such as certain GSL in Brassica spp. family plants or potentially fescue grass infected 
with fungal endophytes (Neotyphodium coenophialum),  and chemical compounds such as nitrates, 
nitriles and perchlorates which can interfere with iodine uptake, thus causing thyroid dysfunction 
[63–66]. 
2.6.1  Type of feed (winter vs summer)  
 
Horses are non-ruminant grazing animals adapted to life in a prairie grassland ecosystem. 
Many horses are stabled throughout the year and may only be fed prepared feeds such as hay and 
concentrate. Winter grazing is typically limited, and most horses are fed or supplemented with 
forage. When provided access to pasture, horses have been observed to graze for 10 - 15 hours per 
day in 10 - 15 feed-bouts [64,67]. Current recommendations include performing a complete 
nutrient analysis with an estimate of the energy content of the hay and concentrates. The quality 
of prepared feed is quite variable and having hay free of excess dust, mold and spoilage is 
important for equine health. Horses have a minimum requirement for forage and it is currently 
recommended that 12.5 g DM per kilogram body weight is fed to horses to meet both behavioural 
and caloric needs[35]. Many horse owners feed concentrates to their horses as they believe the 
energy requirements of the horses are too high to be met by grazing [64]. Concentrates and forages 
in Western Canada are typically very low in important trace minerals such as iodine, copper, zinc 
and selenium [68,69]. North America has many regions with iodine deficient soil, including the 
prairies, and this has historically resulted in goiters in animals and peoples [70,71]. Trace minerals 
are important for thyroid function. Iodine is required to synthesize thyroid hormone, and zinc, 
copper and selenium are required for general metabolism [65]. Additionally the tissue deiodinases 
that convert T4 to T3 are selenoproteins, and selenium is a component of glutathione peroxidase 
[72]. Soils and feeds in Saskatchewan are often low in these four nutrients, and this may result in 
mineral deficiencies [68]. Soil zone is an important determinant of copper status in cattle [73]. 
While there is little information on horses, copper and vitamin A levels were noted to be 
higher after summer grazing, while molybdenum and selenium were lower in beef cows [74] . 




has been shown to decrease in nutritive value over time as the plants mature [64]. Mature forage 
has limited amounts of these vitamins [68]. Pastures across western Canada are known to contain 
a large variety of weeds, most of which are not native to North America [75]. Heat maps of where 
the weeds are found are available. Many of these weeds contain nitrates or GSL [75]. Additionally, 
volunteer plants from adjacent oil seed crops are also present in some locations.  
 
2.6.2 Type of mineral supplements 
  
Horse owners have access to a variety of feed products and may provide minerals in the 
form of blocks, loose salt or mineral mixtures, and ration balancers. Voluntary intake of mineral 
supplements is variable and ranges from 30 – 60 g per day [68]. Salt consumption may range from 
10 – 100 g per day. Lactating mares and working horses may consume more salt, and will consume 
more loose salt than salt from a block [68,76]. Due to various regional differences different types 
of mineral blocks or mineral mixtures may be recommended [77]. Salt blocks were developed for 
cattle and may not be the optimum product for mineral supplementation of horses. It is common 
to mix mineral and iodized salt to increase intake in horses [68], others may choose to top dress 
minerals onto a concentrate ration. As Saskatchewan forage and water sources may contain high 
levels of alkaline salts, livestock may not crave salt, which is used as the main means of providing 
iodine [68]. 
 
2.6.3 Commercial supplements  
 
Table 2.4 shows trace mineral content of a number of equine supplements.  
Table 2.4. Select trace mineral content of a number of commercial supplements commonly fed to 
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2.6.4 Organic vs inorganic iodine  
 
There are a variety of ways of supplementing iodine (I2) to livestock in feeds. Most involve 
the addition of inorganic iodine compounds. Iodide (I-) and iodate (IO3) feed additives are common 
such as: anhydrous calcium iodate [Ca(IO3)], potassium iodide (KI), potassium iodate (KIO3), 
cuprous iodide (CuI), sodium iodide (NaI), sodium iodate (NaIO3), sodium periodate (NaIO4)  or 
organic iodide such as casein bound iodine supplements, or ethylene diamine dihydroiodide 




reported to be very stable. In tropical environments potassium iodide and potassium iodate are 
preferred because of their stability (WHO 2007). Iodate is reduced during the process of digestion 
and is absorbed as iodide [78].  
There have been a number of feed trials that show no major difference in livestock 
performance when similar amounts of different iodine sources are utilized within the 
recommended ranges [81]. The retention of iodine may be affected by the type of iodide fed [82]. 
Milk iodine is determined largely from the level of iodine in the feed, although in dairy cows a 
significant level of iodine in milk is derived from iodine based teat dips and sanitizer [83,84]. 
Fortification of animal feed with iodine has been one means of delivering iodine to human 
populations, as higher levels of iodine supplementation in feed has resulted in higher iodine 
levels in milk and egg yolks [79].  While regulations concerning mandatory salt iodization have 
prevented a large number of iodine deficiency disorders, iodine deficiency still impacts 1.6 
billion people worldwide [85]. Important source of dietary iodine include: seafood, fish, 
seaweed, and cow’s milk which is one of the most common sources of iodine for people in many 
countries [79]. 
 
2.6.5 Microminerals and substances that are goitrogenic or are antagonistic to iodide 
uptake 
A variety of other compounds or minerals called iodine antagonists affect the absorption 
of iodide or they disrupt the function of the thyroid. Mechanisms that may be impacted include 
changes in or disruption of: iodine (I2) transport, thyroid peroxidase level/activity, thyroid 
hormone-binding proteins, hepatic catabolism, deiodinases, and receptor binding [86]. Many 
animals that exhibit one trace mineral deficiency on close examination will be found to have 
deficiencies in other minerals. Common trace mineral deficiencies include: iodine, selenium, 
copper and zinc; however in humans vitamin A and folate may also be lacking and are required 
for thyroid health [65,68,87]. The effects of various minerals on thyroid function has been 
reviewed by Sarne 2016 [87]. 
Calcium. Calcium has been reported to be goitrogenic when fed in excess. Administration of 2 g 
calcium per day decreased iodide clearance by the thyroid and reduced the absorption of T4 [87]. 




access to round bales of alfalfa which are known to contain high amounts of calcium, which may 
lead to a dietary imbalance in calcium and phosphorus [68].  
Bromine. Bromine is a halide element that occurs naturally in the environment, but 
environmental levels in some areas have been increased by use of bromine in pesticide sprays 
and due to pollution from industrial processes. Bromine is concentrated by the thyroid gland and 
interferes with the uptake of iodine in animals and people, probably by competitive inhibition of 
iodide transport into the thyroid follicular cells. Bromine concentrations in high amounts in 
animal feed produces disease, lowers thyroid iodine concentrations, and causes liver damage 
[88]. It is worth mentioning that Bromine has been identified in the formation water associated 
with Potash mines in the province of Saskatchewan [89]. 
Rubidium. Rubidium is an alkali metal which is goitrogenic in rats and accumulates in abnormal 
thyroid tissue; however, the mechanism of action is unknown [87,90]. Rubidium is a highly 
reactive element and oxidizes when in contact with water. It is used in nuclear imaging.   
Fluorine. Fluorine is an element that is not concentrated by the thyroid. In high concentrations it 
has been shown to be goitrogenic in animals, but levels associated with endemic fluorosis are not 
sufficient to interfere with thyroid function or to produce goiter. Iodine deficiency may be 
exacerbated by high dietary fluorine, and contribute to goiter formation [87] . There are two 
mechanisms by which fluorine causes thyroid dysfunction; inhibition of the Na+, K+ ATP ase 
activity and NIS gene expression, thus, decreasing iodine uptake not only by the thyroid gland 
but by gastric mucosa and mammary gland tissue [91]. Fluoride poisoning in endemic areas have 
been reported in various domestic animals, including the horse, with dental and severe skeletal 
fluorosis. The clinical signs include intermittent lameness, hoof deformities, and periosteal 
exostosis [92]. 
Cobalt. Cobalt has been reported to inhibit iodine binding by the thyroid. Cobalt deficiency 
causes a reduction in type I monodeiodinase activity and a decrease in T3, while cobalt excess 
may produce goiter and decreased thyroid hormone production, and has been used to treat 
thyrotoxicosis [87]. Cobalt and iodine containing salt blocks are a common mineral supplement 




Cadmium. Administration of cadmium has been reported to have variable effect in humans 
where thyroid hormones increase and in rats or mice and serum levels of T4 and T3 decrease 
[86]. Cadmium also decreases the activity of hepatic Type I - 5’Deiodinase [87]. 
Lithium. Lithium has been utilized in the treatment of manic-depressive psychosis in humans. 
Lithium administration increases thyroid weight and slows thyroid iodine release. Lithium is 
concentrated by the thyroid, it inhibits the adenylate cyclase activity, blocks the cAMP-mediated 
translocation of thyroid hormone and stabilizes thyroid microtubules, hence there is a 
corresponding increase in the intrathyroidal iodide concentration. Hypothyroidism results in up 
to 40% of patients treated with lithium, and the prevalence of goiter has been reported to be as 
high as 60%, and lithium therapy has been infrequently associated with the development of 
thyrotoxicosis [87]. 
Selenium. The thyroid contains high levels of selenium. Selenium is integral to thyroid function 
because it is contained in glutathione peroxidase (GSH-Px) and superoxide dismutase. 
Additionally, deiodinase enzymes contain selenium and are sometimes referred to as 
selenoenzymes. Most references that show positive relationships between iodine and selenium 
are from animal studies [93]. Selenium deficiency could exacerbate iodine deficiency by 
impairing the ability to regulate oxidation and may lead to decreased peripheral conversion of T4 
to T3 [94] . Treatment of goitrous children with selenium and iodine deficiency leads to a 
reduction in serum TSH and goiter size. The response was correlated with the baseline selenium 
level. In an epidemiological study in China, low selenium levels were associated with an 
increased incidence of goiter, sub-clinical and overt hypothyroidism and thyroiditis [87]. 
Zinc. Zinc is one of the micronutrients commonly deficient in humans and livestock [68]. The 
level of zinc is positively correlated with iodine [65]. Thyroid hormone binding transcription 
factors contain zinc, but whether they are affected by deficiency is unknown [87]. 
Iron. Adequate iron is needed for good general health. The combination of iodine and iron 
deficiency contributes to parasitosis [95]. Iron level is also positively associated with iodine [65]. 
Copper. Dietary copper utilization is sensitive to inhibition by other minerals that may be 




the bioavailability, absorption and accumulation of copper [94]. Copper deficiency results in 
changes in selenoglutathione peroxidase activity and selenodeiodinase enzyme activity in rats 
[87]. In horses copper deficiency causes changes in hair coat colour, limb deformities, immune 
system dysfunction, and connective tissue problems [96,97] .  
 
Nitrates. A concentration of 0.3 - 0.9% nitrate in the diet can interfere with 131I uptake by 
affecting the sodium iodine symporter in the thyroid. Significant concentrations of nitrate are 
found in pasture weeds and in some types of hay and silage [75,98]. Heavily fertilized pastures, 
weather stress on grasses in pastures, water contaminated with nitrate run off, green feed 
(immature cereal hay), and grazing in pastures with nitrogen containing weeds have been 
associated with hypothyroidism in horses and other livestock species [6,79,98]. Nitrate exposure 
has been linked to thyroid dysfunction in people [99].   
 
Perchlorates. Perchlorates are substances that occur naturally in the environment but are also 
used in manufacturing processes and are contained in fireworks, munitions and are associated 
with environmental pollution. Perchlorate levels are often monitored in drinking water. 
Perchlorate is an anionic iodine uptake inhibitor. The mechanism of action is competitive 
inhibition of the sodium iodide symporter. Perchlorate exposure has also been associated with 
decreased free T3 and elevated TSH in humans. Higher exposure levels are likely of concern 
when iodine levels are low and demand for iodine is high such as during pregnancy. Perchlorate 
has been measured in human colostrum but was not correlated with colostrum and milk iodine 
level [36,53]. Nitrate and cyanide (SCN) levels are reported to be more important as iodine 
uptake inhibitors than perchlorates in most settings [99]. Perchlorates have been identified in 
cow’s milk and feed. Levels of perchlorate in milk were associated with a source of water used 
for the irrigation of alfalfa that was known to be contaminated with industrial pollution [100]. 








2.7 Thyroid function assessment in the horse  
2.7.1 Basal hormone analysis  
 
Basal TT3 and TT4 single point measurements are not considered to be reliable indicators 
of thyroid function in the horse, dogs, cats and humans. The majority of the circulating TT4 is 
bound to plasma proteins such as thyroxine binding globulin, serum albumin and transthyretin, 
and its production depends on metabolic rate and energy utilization, thus TT4 concentrations can 
be altered by a wide variety of medications and pathophysiologic states. Administration of 
phenylbutazone causes a decrease in TT4 levels by competing for binding carrier proteins, 
whereas, dexamethasone administration has been reported to decrease TT3 levels by inhibiting 5’-
monodeiodinase. Similarly, high training levels, decreased appetite and food deprivation can alter 
THs circulating levels. Thus, it is recommended to avoid any type of medication for at least two 
weeks before assessing THs concentrations [19,101]. Likewise, TT3 levels have been reported to 
be within the normal range in canine hypothyroidism presumably due to compensatory 
mechanisms during the first stages of thyroid dysfunction [102]. It is worth mentioning that 
assessing fT4 by equilibrium dialysis or using an ultrafiltration method is reported to be more 
accurate if a single point measurement must be utilized, as free THs fractions are not directly 
influenced by the binding capacity to proteins. However, commercial diagnostic kits are not widely 
available for equine samples, are costly and it has been reported that measuring fT4 by direct serum 
analog assays results in a lower value compared to equilibrium dialysis [101]. 
 
2.7.2 Stimulation tests TSH, TRH  
 
Measuring thyroid hormone concentrations and TSH levels by administering TSH or TRH 
to stimulate THs and TSH release is considered the most reliable indicator of thyroid function in 
the horse compared to single time point measurements. Nevertheless, the test requires blood 
samples at different time points, making it less efficient to perform in the field [19]. The TRH 
stimulation test consists of a single injection of TRH (1 mg - adult horse; 0.5 mg - foal) or TSH (5 
IU) intravenously followed by blood sampling at 2 and 4 hrs post TRH injection. The T3 
concentrations are expected to double at 2 hours post TRH injection compared to basal levels, 




that horses with high T4 and T3 resting values tend to fail to double their values after TRH, 
whereas, low resting values tend to have a higher response after the stimulation test, also, T4 and 
T3 peaks may happen either earlier or later than the time points previously mentioned in individual 
horses[19]. For that reason, a 1.3 – 3.8 fold increase over the basal TT4 level at 4 hours post-TRH 
administration or a 1.1 – 10.3 fold increase over the basal TRH TT3 levels at 2 hours post-TRH 
administration have also been reported to be related to an adequate response from the thyroid gland 
[19]. Meredith et al. (2004) reported a mean increase in T3 of 4.5 fold at 2 hrs post TRH, and 
showed no association with response to TRH and pregnancy rates [103]. It is worth mentioning 
caution should be taken when interpreting the results due to the inherent variability that is present 
in the test. 
 
2.7.3 Ultrasound examination 
  
There is some published information on the relationship between ultrasonographic 
dimensions of the thyroid gland and thyroid function in horses. The normal values for the 
dimensions of the equine thyroid gland measured by ultrasonography were reported by Davies et 
al. (2010) in a group of 10 horses, and described the use of an ellipsoid calculation that included 
the length, width and height of the gland [π /6 (length x width x height)] [14,15]. Viana et al.  
(2019) studied 11 horses and utilized (length x width x height) cm3 to calculate thyroid volume 
[15]. Davies et al. (2010)  reported a combined mean thyroid gland volume (cm3) of 27 – 37 cm3, 
and Viana et al. (2019) reported about 24 cm3  [17,18]. The ultrasound evaluation is performed 
by applying mineral oil and/or alcohol in an area of approximately 6 x 6 cm caudal to the larynx 
on either side of the neck. An ultrasound machine with a 7.5 – 5 MHz linear probe with 
standardized power, and gain settings (G92, P100) can be used to examine both thyroid glands 
by displaying longitudinal images of each thyroid lobe to assess length and height (mm), and 
transverse images for width (mm) measurements using the internal callipers.  
One of the goals of ultrasonographic assessment is to help determine whether the thyroid 
gland is within normal limits, enlarged, or smaller than average. Assessment of thyroid size is 
best performed by correcting for body weight or body surface area. Schotthauer (1931) reported 
a range of 0.02 – 0.06 g thyroid per kilogram of body weight as the normal range in a necropsy 




[71]. Unilateral or bilateral enlargement may also be due to cystic and/or nodular structures that 
can be compatible with tumours or an increase in thyroid gland parenchyma [19]. In humans, 
ultrasound-guided fine needle aspiration biopsy (FNA) of the thyroid gland in relation to 
cytological features and ultrasonographic findings have been successfully used in the early 
diagnosis of thyroid cancer. Nodule size (>10 mm) along with ultrasound features such as 
marked hypoechogenicity, microcalcification areas, microlobulated nodules with/or irregular 
margins and taller rather than wide appearance have been reported to be associated with 
suspicious malignancy [15,104,105]. However, in horses there are no large studies performed in 
this area.   
 
2.8 Thyroid dysfunction in the adult horse  
Thyroid dysfunction can result from a decrease in the production of THs, a deficient thyroid 
activity or a disruption in HPT axis. Hypothyroidism is classified in three categories: primary 
hypothyroidism refers to the inhibition of thyroid hormone synthesis such as arises due to iodine 
excess or deficiency, thyroid neoplasia and goitrogenic compounds affecting the thyroid gland; 
secondary or central hypothyroidism refers to dysfunction at the pituitary or hypothalamic level; 
and tertiary hypothyroidism results in the failure of THs to exert their effects in peripheral tissues 
[10].  
 
2.8.1 Primary hypothyroidism 
  
The prevalence of primary hypothyroidism in adult horses is questionable. In dogs and 
humans, primary hypothyroidism is typically caused by autoimmune diseases and is commonly 
seen in clinical practice. Perillo et al. (2005) reported histologic changes, such as lymphocytic 
infiltration and fibrosis with progressive destruction of the thyroid gland, consistent with 
Hashimoto’s thyroiditis like disease in 80% of the 156 thyroid glands recovered from 622 
slaughtered horses in Eastern Europe [106]. Interestingly, the same group measured serum 
thyroglobulin levels in 9 horses with histologic changes similar to human Hashimoto thyroiditis, 
and reported levels to be significantly higher compared to euthyroid horses. However, it is 




seen in dogs and humans. Similarly, a case of equine iatrogenic hypothyroidism in a 14-year-old 
gelding that was receiving 60 g/day of potassium iodide for 15 days was reported in Brazil 
(recommended daily intake is 0.00315 g). The most relevant clinical signs were decreased 
intestinal motility, hyperthermia, lethargy, goiter, reluctant to move and basal TT4 levels of 0.10 
µg/dl [107]. There are a number of case reports from horses that received too little or too much 
dietary iodine which resulted in thyroid dysfunction [45,70,107–109]. There is one report of a herd 
of horses affected by primary hypothyroidism that was related to exposure to goitrogenic plants 
[110]. 
In addition, primary hypothyroidism has also been documented experimentally. Breuhaus 
(2002) reported THs and TSH serum levels after TRH stimulation test in euthyroid and induced-
hypothyroid horses with the highly goitrogenic compound called propylthiouracil (PTU) in a 6-
week period at a dose of 4 mg/kg daily [111]. Even though none of the horses showed clinical 
signs, basal TT3 and fT3 were markedly decreased after one week of PTU administration, whereas, 
TT4 was significantly decreased until the 4th week and TSH was dramatically increased until the 
5th week of PTU treatment compared to euthyroid horses. In addition, THs failed to double after 
the TRH stimulation test, whereas TSH levels significantly increased 45 min after TRH injection 
due to the lack of negative feedback from adequate levels of circulating THs [111]. 
Propylthiouracil’s affects THs synthesis as it inhibits iodination of the thyroglobulin tyrosine 
residues by blocking the TPO enzyme even if adequate iodine supplementation is present [112].  
Other authors reported similar effects of PTU on thyroid function in horses using a similar protocol 
[33,113]. 
 
2.8.3 Nonthyroidal illness syndrome  
 
Central or secondary hypothyroidism, also referred as nonthyroidal illness syndrome, is 
characterized by a lack of response of the HPT axis resulting in low THs levels, but also can result 
in a decrease in thyroid hormone binding proteins in bloodstream. Nonetheless, the thyroid gland 
itself is apparently normal [114]. Factors such as phenylbutazone and dexamethasone 
administration, high energy and protein diets, level of training, food deprivation and ingestion of 
fescue grass containing endophyte have been reported to decrease THs levels. Studies have shown 




the last day of treatment and T4 remained low for approximately 10 days. Phenylbutazone has 
high protein binding and it displaces TH, thus, high fT4 levels remain high resulting in inhibition 
of the HPT axis. Similarly, low leptin levels caused by food deprivation or prolonged fasting for 
periods of time reduce the thyroid hormone negative feedback on TRH release [4,19].  
On the contrary, nonthyroidal illness syndrome in neonatal foals is believed to be an 
adaptive response to systemic inflammation in order to prevent organ failure and death in critically 
ill foals[115]. Himler et al. (2012) discussed the mechanisms that are believed to cause low THs 
concentrations in this syndrome; in septic rats, an increase pro-inflammatory cytokines such as 
interleukin -6, tumor necrosis factor α, and interleukin -1β can inhibit 5’deiodinase activity, and 
an increase in iodine utilisation by neutrophils has also been observed to contribute to decrease 
THs concentrations [115]. 
 
2.8.4 Diagnosis and treatment  
 
Diagnosis of hypothyroidism based on clinical signs alone is not reliable and as signs are 
inconsistent among horses. Thyroidectomized horses can present with clinical signs such as: 
hypothermia, coarse haircoat, limb edema, lethargy and abnormal growth rate in growing horses 
[113]. In addition, exercise intolerance, alterations in the cardiovascular system, and in some cases 
goiter have been reported [114]. Laboratory diagnosis includes low basal serum TT4 and TT3 
concentrations, but because of baseline variability, are only supportive of the diagnosis of 
hypothyroidism in horses. It has been stated that horses should not be diagnosed as hypothyroid 
until it has been proven that the HPT axis is disrupted; however, the effects of various compounds 
and goitrogens on the HPT have not been thoroughly investigated in horses. As discussed above, 
several factors such as non-thyroidal illnesses and medications, can decrease THs levels without 
affecting the thyroid gland, thus, to differentiate primary hypothyroidism from other abnormalities 
in the HPT axis, TSH concentrations should be assessed. Below normal serum levels of free and 
total THs along with elevated TSH concentrations are indicative of primary hypothyroidism, 
whereas, low THs concentrations can result from other disturbances in the HPT axis [4]. The TSH 
assay is not commercially available for horses, and elevations in TSH are more commonly 
associated with autoimmune disease in animals such as dogs [116].  Furthermore, a TRH 




axis. Failure to double the basal value at 2 hr and 4 hr for T3 and T4, respectively, can suggest 
thyroid dysfunction; however, the test cannot confirm primary hypothyroidism unless TSH levels 
are assessed after TRH administration. Thyrotrophin levels should increase at 45 minutes after 
TRH administration, and should be more than double compared to basal resting values [4,19].   
Ultrasonographic evaluation is recommended to determine if the enlargement of the thyroid 
gland is derived from neoplastic areas and or/cystic structures or if the gland itself is enlarged 
(goiter) [117]. Furthermore, a diagnosis of thyroid dysfunction based on necropsy is made mainly 
on the thyroid gland weight per kg body weight, and histological findings in goitre include; 
hyperplastic thyroid gland epithelium, and small, irregular size follicles with minimal amount of 
colloid which has been reported in cases of adult thyroid disease, and in foals with congenital 
hypothyroidism syndrome [70,71,118]. 
Thyroid hormone supplementation, mainly thyroxine, has been prescribed to horses with 
suspected hypothyroidism and with other endocrinologic diseases, such as equine metabolic 
syndrome (EMS). Iodinated casein, which contains 1% T4 (“Thyroprotein”) at a dose of 5 to 15 g 
per day orally and the synthetic thyroid hormone called levothyroxine  sodium (L-T4), with doses 
ranging from 20 µg/kg BW per day to as high as 50 to 100 µg/kg BW per day orally are 
commercially available for horses [19]. Healthy mares receiving increasing doses of L-T4 starting 
at 24, 48, 72 and 96 mg per day for 8 weeks resulted in a median weight loss of 19 kg compared 
to 4 kg for the non-treated mares; TT4 basal concentrations were positively correlated with time, 
whereas TSH concentrations decreased by week 8 compared to week 0. In addition, TT4, TT3 and 
fT3 concentrations after a TRH stimulation test decreased significantly overtime with no 
significant effect on fT4 concentrations [119]. It is worth mentioning that heart rate (HR), 
respiratory rate (RR) and body temperature did not change among groups, however, changes in 
behaviour, such as being more excited and agitated, were observed only with 96 mg of L-T4, with 
no behavioural effects at dosages of 24, 48 and 72 mg [119]. Similarly, the effects of long-term 
oral administrations of L-T4 at a dose of 48 mg/day for 48 weeks on thyroid hormone 
concentrations and health status were assessed. Overall, basal TT4 concentrations increased 
overtime, whereas thyroid hormone responses to TRH stimulation decreased, there was enhanced 
body weight loss and there were no negative effects on general health in euthyroid mares [120]. It 




due to the suppression effects of exogenous L-T4 on the HPT axis. To the authors knowledge, 
there is a lack of information regarding the effect and pharmacokinetics of L-T4 on hypothyroid 
horses. 
2.9 Thyroid dysfunction in foals  
Low levels of THs have been  associated with prematurity [121], but may also be related to 
severe illness in mature foals, as described by Breuhaus (2014), who compared resting T4 and 
T3 levels in 24-36 hrs old normal, sick and premature foals. Premature foals that died had a 
median (range) nmol/L TT3 and TT4 levels of 1.8 (0.4-7.4) and 127 (54-299), respectively,  
versus 4.3 nmol/L (1.3-15.9) for TT3 and 247 nmol/L (92-319) for TT4 in sick foals with a good 
survival prognosis, and 8.2 nmol/L (6 - 11.8) for TT3 and 260 nmol/L (191-318) for TT4 in 
healthy foals. As described above, despite the severity of the illness, sick foals with a mature 
HPA axis that experienced low TT3 levels resulting from the negative effects of inflammatory 
cytokines on T4 deiodination, had better survival rates compared to premature foals that had low 
TT4 circulating levels, suggesting that high mortality rates may be directly related to the 
inadequate maturation of the HPA axis, which may affect thyroid hormone responsiveness 
against the high metabolic demand in the neonatal period [24].  
Furthermore, Panzani et al. (2012) demonstrated similar patterns of THs levels between 
spontaneous and induced foals in the first week of life, suggesting that if induction to parturition 
is performed when the fetal HPA axis is matured, there are no negative effects on neonatal 
survival and THs production. On the contrary, foals hospitalized for hypoxic ischemic 
encephalopathy and sepsis resulted in lower THs levels compared to spontaneous and induced 
healthy foals [122]. It has been suggested that hypoxia can activate the release of inflammatory 
cytokines such as tumor necrosis factor-	alfa, which have been found in higher concentrations in 
the cerebrospinal fluid and serum from newborn infants experiencing hypoxic-ischemic 
encephalopathy, causing a decrease in THs production, similar to what has been reported in 
septic rats [115,123]. 
 
2.9.1 Goitre – iodine deficiency and excess 
 
Congenital goiter is defined as an enlargement of the foal’s thyroid gland along with low 




ingestion of toxins or goitrogenic plants during pregnancy [19]. In early stages of iodine 
deficiency, there is a transient  increase in TSH secretion by the pituitary gland, which increases 
sodium iodide symporter activity to enhance iodide uptake by the thyroid gland along with a 
reduction in renal clearance and an increase in reutilization of iodine from THs degradation with 
no effect on circulating THs concentrations [124]. However, in moderate to severe iodine 
deficiency, TSH levels are maintained at a high level and T4 levels decrease with no change in T3 
levels. In chronic cases, T3 levels are also low, and goiter will arise as a result of a lack of iodine 
for THs synthesis despite constant TSH release [124]. On the contrary, a compensatory effect after 
ingesting a large amount of iodide has been reported in rats since 1940. The acute Wolf-Chaikoff 
effect is characterized by a decrease in THs synthesis lasting 24 hours. It has been postulated that 
an abrupt increase in intrathyroidal iodine levels inhibits the thyroid peroxidase and intrathyroidal 
deiodinases activity, thus decreasing THs synthesis. However, in euthyroid people, there is an 
increase in renal iodine clearance and the sodium iodide symporter activity decreases its 
expression, thus, active transport of iodine into the thyroid gland is decreased to resume normal 
TH production [125]. Nevertheless, a fetus in utero or an adult with a previous history of thyroid 
dysfunction may fail to escape the Wolf-Chaikoff effect, which means that the thyroid gland is 
unable to activate the regulatory mechanisms that allow the prompt resumption of normal thyroid 
function, causing thyroid gland hyperplasia [125]. Despite an iodine excess or deficiency, the low 
THs circulating levels causes an increase in TSH release, the thyroid gland increases iodine uptake 
and T4 synthesis; however, there is a continued stimulation of the thyroid gland via TSH signaling 
as there is no negative feedback, which leads to hypertrophy and hyperplasia of the follicular 
epithelial cells, a lack of colloid and an increase in vascularity [118].  
 
2.9.2 Congenital hypothyroidism dysmaturity syndrome 
 
In the 1980s, a syndrome of thyroid gland hyperplasia and moderate to severe 
musculoskeletal abnormalities (TH-MSD) such as angular limb deformities, rupture of the 
common digital extensor tendon as a result of severe contracted tendons, mandibular prognathia 
and failure of carpal and tarsal bone ossification in neonatal foals was first described in western 
Canada [126]. Allen et al. (1994) reported the prevalence of the syndrome in a ten-year period. 




2.7% were affected by the syndrome and 2.5% of these cases had evident thyroid gland hyperplasia 
[126]. A case definition was developed [6,126]. In addition, the majority of the affected foals had 
prolonged gestation with a mean of 360 days with moderate to severe signs of immaturity and 
were hypothermic at birth. These foals had low basal levels of thyroid hormone and failed to 
respond to TSH [54,60]. A proportion of CHDS foals have adenohypophyseal hyperplasia of 
thyrotrophs [118,126,127]. For that reason, the term congenital hypothyroidism and dysmaturity 
syndrome (CHDS) in foals has been used to better exhibit the pathogenesis of the disease. Initially, 
CHDS was exclusively reported in western Canada, but it has also been reported in the pacific 
northwest region of the USA, eastern Canada and Europe [128]. Koikkalainen et al (2014) 
described the clinical and pathological features of CHDS cases reported in Europe [118]. The most 
remarkable clinical signs seen in all the cases were weakness and inability to stand, rupture of the 
common digital extensor tendon, incomplete carpal and tarsal bone ossification, mandibular 
prognathism, hypothermia and dysmaturity. It is worth mentioning that evident goiter was not 
reported in all cases; however, histologically, there was a marked hypertrophy and hyperplasia of 
the follicular epithelium of the thyroid gland in all cases, and all foals had low THs concentrations 
compared to normal values for neonatal foals, and enlarged pituitary glands which is consistent 
with primary hypothyroidism [118].  
The exact aetiology of CHDS remains unknown, but risk factors such as exposure to 
nitrates and goitrogenic substances such as mustard plants, along with low trace mineral 
supplementation (mainly iodine and selenium) during pregnancy have been associated with the 
syndrome [118]. Western Canada is well known for the high production of GSL containing crops 
such as canola (Brassica family type), rapeseed, mustard seed as well as wild plants that can 
contain goitrogenic substances such as nitrates and GSL [75].  
 
2.9.3 Diagnosis and treatment  
 
Diagnosis of thyroid dysfunction in the neonatal foal is based on clinical and radiographic 
signs, histological findings and thyroid hormone levels. Due to the essential role of THs during 
normal organ development and growth, the clinical signs tend to be more significantly severe 
compared to an adult horse. In normal neonatal foals, THs concentrations are higher in the first 




low THs levels and failure to respond to the TRH stimulation test along with clinical and 
radiographic signs previously discussed and thyroid gland hyperplasia confirmed by histology are 
considered diagnostic. Nevertheless, determining the cause is still challenging for the equine 
practitioner as there is a lack of robust information regarding normal milk and serum iodine 
reference ranges in neonatal foals that can help in the determining whether the cause was an excess 
or iodine deficiency.  
Prevention of CHDS includes adequate mineral supplementation, mainly iodine and 
selenium, in areas with iodine and selenium deficient soils and avoiding heavily fertilized pastures 
and pastures with goitrogenic plants during pregnancy. Levothyroxine (T4) at a dose of 20 to 50 
µg/kg/ day and T3 at 1 µg/kg/day orally has been administered to severely affected neonatal foals, 
however, the response is questionable [19]. Foals have extremely high thyroid hormone levels at 
birth that decrease over time which may be related to a reduced demand for iodine and hence foals 
if they survive become euthyroid over time [19,118]. 
 
2.10 Glucosinolates 
2.10.1 Chemical structure and source 
 
Brassicaceae family vegetables such as Brassica oleracea (cabbage, broccoli, cauliflower, 
kale and brussels sprouts) and Brassicaceae family plants including oil seed crops of B. napus 
(rapeseed meal) and B. juncea (mustard) contain bioactive metabolites stored in intracellular 
vacuoles in the root, seed, leave and stem, such as GSL, erucic acid and other sulphur compounds, 
that act as a defense mechanism against animals, insects, bacteria and fungi [129]. Nearly 200 
different types of GSL have been identified and are composed of a sulfur bridge along with a β-
D-thioglucose group, a sulphonated oxime moiety and a variable aglycone side chain composed 
of different amino acids [66]. They are classified into three main groups based on the amino acid 
precursor: aliphatic GSL (alanine, leucine, isoleucine, methionine), indole GSL (tryptophan) and 
aromatic GSL (phenylalanine or tyrosine) [130]. GSL composition and concentration are different 
among plant species, and highly depends on external stimuli such as climatic conditions, 
agronomic practices (harvest, fertilization) and stage of feed production. For example, short-term 




harvested crops have higher GSL levels compared to winter harvest, and it has been suggested that 
hot dry environments along with lack of water can increase the formation of sugars and amino 




Glucosinolates themselves are biologically inactive, but secondary metabolites produced 
by their degradation through the glucosinolate-myrosinase system are known to exert biological 
effects, and the negative effects are correlated with the concentration and type of GSL present in 
the plant. Once the plant is mechanically damaged, GSL is released and hydrolyzed by a 
thioglucoside glucohydrolase enzyme called myrosinase, which is present in the plant and in the 
intestinal microflora [66,130]. Major GSL found in plants are sinigrin, progoitrin, glucobrassicin 
and glucoraphanin. Progoitrin or L-5-vinyl-2-thiooxazolidine is mainly found in rapeseed meal 
(Brassica napus), and it is hydrolyzed into goitrin, a potent goitrogenic metabolite that blocks 
iodination of tyrosine residues, thus, inhibiting T4 synthesis. Sinigrin is hydrolyzed into allyl 
isothiocyanate, whereas glucobrassicin and glucoraphanin’s main metabolites are thiocyanates, 
isothiocyanates or nitriles. [130–132]. Isothiocyanates, thiocyanates and sinigrin are responsible 
for the bitter taste that reduces feed intake and are reported to interfere with iodine uptake by the 
thyroid gland, thus causing thyroid dysfunction. 
 
2.10.3 Interaction of iodine with glucosinolates  
 
Secondary GSL metabolites such as thiocyanates, isothiocyanates and allyl isothiocyanates 
can alter the iodine uptake by the thyroid gland through different pathways. It has been reported 
that they: increase iodine efflux by facilitating urine excretion, interfere with the thyroid 
peroxidase activity, inhibit the incorporation of iodine into thyroglobulin and inhibit the sodium 
iodine symporter, which not only decrease iodine uptake by the thyroid gland [66,133], but can 
also affect the uptake of iodine by the mammary gland [134,135]. Chandra et al. (2016) published 
information about the prevalence of goiter in 6 to 12-year old children located in areas with high 
iodine supplementation. The mean urinary iodine (UI) concentration was 231 µg/L (adequate 




the population; but not toxic as UI concentration ³ 300 µg/L is considered toxic and is associated 
with thyroid dysfunction in humans. Despite adequate iodine intake and the prevalence of goiter 
was high in this population, mean urinary thiocyanate (0.857 ± 0.486 mg/dl) was significantly 
higher compared to non-endemic goiter areas (0.504 ± 0.197 mg/dl), and a positive correlation 
between urinary excretion of iodine and thiocyanate was identified, suggesting a relationship 
between goiter and thiocyanate consumption in this population. High urinary thiocyanate levels 
were associated with the consumption of bamboo shoot which contains progoitrin. It is worth 
mentioning that water hardness was significantly higher, ranging from 210 to 618 ppm due high 
levels of solids including salt and iodine. The authors reported that other factors can contribute to 
the high goiter prevalence in the area [133,136]  
Similarly, the effect of thiocyanates on iodine levels in cow milk has been reported. Dairy 
cows exposed to rapeseed meal or rapeseed press cake with GSL concentration of 50-100 mmol/kg 
resulted in a decrease in iodine level in milk by one half to three quarters compared to cows 
receiving a rapeseed meal-free diet, suggesting that the sodium iodine symporter activity in the 
mammary gland is also affected by the presence of thiocyanates[83,135].  
Franke et al. (2009) reported the effect of rapeseed meal (RSM) and two different types of 
iodine supplementation on blood, milk, urine and fecal samples in dairy cows. There was a 
significant increase in serum iodine, fecal and urinary iodine levels, whereas milk iodine levels 
were significantly decreased after exposure to RSM suggesting a reduction in iodine transfer to 
the mammary gland and thyroid gland. On the contrary, cows fed the diet without RSM with iodine 
supplementation had higher iodine excretion through milk, urine and feces [137].  
 
2.10.4 Glucosinolates and thyroid function in horses and ruminants  
 
Type and concentration of GSL are not the only factors associated with the severity of the 
adverse effects of GSL, but tolerance among animal species and age play a key role in the side 
effects. It has been reported that ruminants are less sensitive to feeds containing GSL compared to 
monogastric animals such as pigs, poultry and fish [66]. The microflora present in the 
gastrointestinal system of ruminants enhances transformation of GSL metabolites, thus decreasing 




induces iodine deficiency in dairy cows and inclusion of 31 µmol/g diet if GSL in the diet can 
result in thyroid dysfunction and decreased fertility. Laarveld et al. (1981) showed the goitrogenic 
effects of Midas RSM diets, at an inclusion rate of 19% resulting in a significant increase in TSH 
levels and lower TT4 levels after TRH stimulation tests in dairy cows [135]. In pregnant sheep, 
rapeseed meal containing 4.2 mmol of GSL for 382 days resulted in a significant decrease in TT4 
and iodine levels in lambs from ewes continually exposed to the RSM diet, and lower iodine levels 
were measured in colostrum and milk [138].  
In addition, Bobek et al. (1992) reported the effects of thiocyanate in various domestic 
animals in southern Poland. Cows exposed to Brassica plants commonly found in the area, where 
there is high incidence of goitre in humans and low levels of iodine in cow milk, resulted in higher 
concentrations of thiocyanate in blood and milk with no evident change in serum iodine levels 
[139]. It was also observed that increased levels of thiocyanate in blood are related to greater 
goitrogenic effects [139]. Similarly, Papas et al. (1979) reported the effects of feeding RSM 
containing low and high GSL concentrations on thyroid hormones, iodine and GSL levels on milk 
in dairy cows and calves. Cows fed the meal containing high GSL content resulted in reduced T4 
levels, and histological changes in the thyroid gland of calves were evident [140]. Rats receiving 
milk from cows fed high GSL meal resulted in increased thyroid gland weights, which was 
prevented by iodine supplementation [140]. It is worth noting that in this study no intact GSL  was 
detected in the milk of cows exposed to rapeseed meal, only inorganic thiocyanate was detected 
[140].  
In horses, to the author’s knowledge there are no studies performed on the effect of GSL 
on thyroid function in horses. Nevertheless, Cymbaluk (1990) and Oliviera et al. (2001) reported 
feeding different levels of canola meal in growing horses with no adverse effects in a 60 - 75 day 
period [141,142]. This suggests that feeding canola meal to horses GSL for short periods of time 
did not cause adverse effects on parameters such as weight gain. The cost benefit of adding various 
GSL containing ingredients to equine feeds has not been determined, as the tolerance to different 






2.10.5 Role of glucosinolates in pregnancy 
 
There is a lack of evidence regarding the presence of secondary GSL metabolites in the 
fetal fluids of pregnant domestic animals. Nevertheless, negative effects of GSL diets on pregnant 
animals have been widely reported. Maternal iodine transfer is essential for adequate fetal thyroid 
hormone synthesis, for that reason chronic exposure to GSL during pregnancy can decrease iodine 
uptake by the maternal and fetal thyroid gland and increase urine excretion, thus causing thyroid 
dysfunction in the fetus. Pregnant sows exposed to chronic rapeseed meal diet without iodine 
supplementation resulted in prolonged gestation and stillborn piglets with enlarged thyroid gland 
and undetectable serum TT4 concentrations. Piglets from sows receiving rapeseed meal without 
iodine supplementation had significantly lower TT4 levels in serum compared to piglets from sows 
receiving iodine supplementation; however, in both sows and piglets iodine serum levels were 
higher compared to control group, suggesting that the lack of iodine transport to maternal and 
thyroid gland may cause an increase in serum iodine levels  [143]. Schöne and Rajendrum (2009) 
have published a review on iodine in farm animals that summarizes many studies [79]. 
Ewes receiving 4.2 mmol of GSL and 4 g of nitrate without iodine supplementation resulted 
in congenital goiter and low iodine and TT4 serum concentrations in the respective lambs, whereas 
colostrum and milk samples had significantly lower iodine levels compared to the control group 
and ewes receiving iodine supplementation [138]. 
 
2.10.6 Methods for determination of glucosinolates  
 
Glucosinolates are chemically stable compounds. A variety of methods have been utilized 
to measure GSL including indirect analyses based on the degradation products of GSL. Some 
assays evaluate the glucose content in the sample, such as the thymol test, which provides an 
estimate of the total amount of GSL. Sinigrin and progoitrin, which are GSL degradation products, 
have been analyzed using ELISA. Indole GSL levels may be detected after reaction with diazotized 
sulfanilic acid and isothiocyanate may be detected by its reaction to 1,2 benzendithiol using 
spectrophotometric methods. Near infrared spectroscopy of samples has been utilized to detect 
GSL but various other chromatographic methods such as ICP-MS, high performance liquid 




concentrations in feed, serum, urine and milk has also been determined using ion chromatography 
tandem mass spectrometry [145,146]. There is no information regarding GSL levels in serum, 
urine and milk from horses.   
For example, a determination of isothiocyanates in human plasma after consumption of 
raw broccoli has been reported. Blood samples were taken with EDTA tubes 3 hours after ingestion 
of broccoli, based on previous research in which the peak of isothiocyanates in blood was seen at 
the time previously mentioned. Initially, the plasma was treated with 100 mM acetic acid in 
methanol, was left on ice for 30 min and was then centrifuged. The supernatant was analysed using 
the liquid chromatography with tandem mass spectrometric detection (LC-MS/MS) for GSL 
content. It is worth mentioning that this method has been used to analyse feed and other biologic 
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3.1  Abstract   
Exposure to plants containing glucosinolates (GSL) affects thyroid function in many 
species, and in horses is implicated in the birth of foals with congenital hypothyroidism. The 
present study was performed to determine the effect of feeding a GSL (sinigrin) in combination 
with low iodine diet for 12 weeks on thyroid hormones and serum iodine concentrations in non-
pregnant mares. Nineteen mares aged 2 to 14 years were divided into Control (n=6), Low GSL 
(20 mmol/day) (n=7) and High GSL (35 mmol/day) (n=6) groups. Thyrotropin releasing 
hormone (TRH) stimulation tests and serum iodine measurements were performed at 0 and 12 
weeks. Total triiodothyronine (TT3), total thyroxine (TT4) and thyroid stimulating hormone 
(TSH) concentrations were compared at baseline and post-TRH samples.  The difference in 
concentrations (D) and fold change (FC) before and after TRH administration was calculated for 
TSH, TT3 and TT4. Data were analysed at P < 0.05. Highlights included post-TRH TT4 and 
TT3 concentrations having a group and week interaction (P < 0.001) with Control mares having 
higher values (P < 0.025) in week 12 than week 0, and Control mares in week 12 having higher 
values than mares in Low and High GSL groups. The TT4 FC values had a group (P <0.001) and 
group by week interaction (P <0.001) with week 12 Control concentrations higher (P < 0.006) 
than all other groups. Iodine concentrations decreased (P < 0.002) over time in GSL mares. In 
conclusion, feeding mares a low iodine diet with 20 and 35 mmol sinigrin/day resulted in lower 
serum iodine concentrations and lower TT4 concentrations responsiveness to TRH at week 12. 
 
3.2 Introduction  
The birth of congenitally hypothyroid foals has been reported in Europe [118]  and North 
America [6]. Hypothyroid foals are called “mustard foals” in the USA, because of the association 
with grazing mares in pastures with wild mustard plants that contain compounds called 
glucosinolates (GSL) [147]. Glucosinolate containing weeds  in the Western Canadian prairie 
region include: Argentine canola (Brassica napus); ball mustard (Neslia paniculate); dog 
mustard (Erucastrum gallicum); flixweed (Descurainia sophia); Polish canola (Brassica rapa); 
tumble mustard (Sisymbrium altissimum); wild mustard (Brassica kaber), and shepherd’s purse 
(Capsella bursa-pastoris); along with cultivated oilseed plants such as: canola (Brassica napus), 




maps have been generated showing the percentage of fields where these weeds are found in the 
Canadian prairies [75]. Most of these plants are present throughout the United States and many 
originated in Europe [75,148].  
The Great Lakes area and prairie regions of North America are known for iodine 
deficient soil [70,109]. Plants such as kale, broccoli, brussel sprouts and mustard plants all 
contain GSL compounds. Low levels of GSL may have beneficial effects on health, but higher 
concentrations may have adverse effects [66]. Sinigrin is a bitter tasting GSL compound found in 
many plants including mustard. When consumed sinigrin is hydrolysed by a plant and intestinal 
enzyme called myrosinase into nitriles and allyl isothiocyanates. Consumption of GSL through 
wild and cultivated Brassica spp. plants may interfere with iodide uptake, because GSL like 
sinigrin, are metabolized into thyroid suppressing compounds such as: thiocyanates, thiouracils, 
isothiouracils and nitriles [112,149].  Diets containing significant amounts of GSL cause 
hypothyroidism in many species including: chickens, pigs, cattle, goats, sheep, buffalo, rodents 
and rabbits, and may affect thyroid function of their offspring because GSL metabolites cross the 
placenta [66,150]. Feeding high amounts of iodide along with moderate amounts of GSL 
ameliorates the effects of GSL on thyroid function [66,150]. Dietary factors, such as the level 
and types of GSL in the diet, other trace minerals, and nitrates affect the uptake of iodide by the 
thyroid through effects on the sodium-iodide symporter and by affecting the organification of 
iodide [35,66]. Different plant species may contain a variety of GSL compounds [66] and GSL 
containing feeds, such as canola meal and rapeseed meal, have been fed to growing horses 
without negative effects [141,142,151]. However, there have been no nutrition trials directly 
assessing the effects of GSL on serum iodine concentrations or thyroid hormones in horses.  
Healthy thyroid function is essential for horses because of the central role of thyroid 
hormones in: thermogenesis, development, metabolism, growth, and reproduction [1]. Thyroid 
health in horses is related to many factors, including iodine intake [19,150]. The relationship 
between dietary iodine deficiency and thyroid disease in horses was recognized in the veterinary 
literature in 1931 and was reported to cause stillbirth, contracted tendons in foals, and goitre 
[70,109]. Currently, extensively managed horses are commonly supplemented with iodine 
through the use of iodized salt blocks and pelletized feeds; however, whether this and other 




Additionally, there are many gaps in our understanding of the effect of physiologic status 
and season on thyroid function.  Fazio et al. (2012) reported intrinsic seasonal fluctuations in 
TT4 and TT3 levels in barren donkeys and in pregnant and non-pregnant mares [30,152]. There 
is little information on the response to TRH in mares in different seasons [25].  Our objective 
was to determine the effects of feeding a low iodine diet combined with a natural GSL (sinigrin) 
obtained from oriental mustard on serum iodine concentrations and thyroid hormone levels in 
mares.  These conditions including low dietary iodine and GSL exposure were created to mimic 
risk factors for mares associated with the birth of foals with congenital hypothyroidism. The 
roles of GSL and current iodine supplementation in thyroid disease in horses needs further 
elucidation. Closing this knowledge gap is important to the equine industry because of the key 
role of the thyroid in equine health and well-being [1,19]. The hypothesis was that feeding a low 
iodine diet combined with the GSL (sinigrin) for 12 weeks would alter thyroid hormone levels 
and decrease serum iodine levels in mares.  
 
3.3  Material and Methods   
3.3.1 Mare Management 
 
University of Saskatchewan’s Institutional Animal Care and Use Committee approved 
the animal use in this study. Healthy non-pregnant light breed mares (n=19) ranging in age from 
2 to 14 years [8.3 ± 0.8 years (mean± SD)] were housed in dry lots with straw bedded shelters. 
The feeding trial was performed for 12 weeks beginning in late September to mid-December 
2017. A physical examination was performed on each mare (temperature, pulse, respiration, 
mucous membrane color, auscultation, palpation of lymph nodes and thyroid, evaluation of 
manure consistency) at the beginning of the trial. Mares were weighed at the start and end of the 
trial.   
 
3.3.2  Feed palatability and source of GSL 
 
A feed palatability trial was performed prior to the start of the experiment. A 500 g 
mustard meal composed of 450 g of oats combined with 50 g (10%) oriental mustard powder 




mares refused to eat feed containing the OMP. Eight mares consumed all of the oriental mustard 
oats mixture, whereas five mares ate half. Therefore, mares that refused the meal were assigned 
to Control (n=6) group, whereas mares that would consume the OMP mixture were randomized 
into the High GSL (n=6) and Low GSL (n=7) group.  
Oriental mustard powder (Sakai Spice, 4201 2nd Ave North, Lethbridge, Alberta, Canada 
T1H0C8) was utilized as the source of GSL. Glucosinolate content of the OMP, oats and hay 
used in the study was analyzed at the Lipids Quality and Utilization Lab, College of Agriculture 
and Bioresources, University of Saskatchewan, Saskatoon, SK Canada, and only the OMP was 
found to contain the GSL, sinigrin, at 128.9 mmol / kg. Sinigrin is a GSL whose secondary 
metabolites include isothiocyanates and nitriles.  
 
3.3.3  Diets 
 
  An isocaloric and isonitrogenous diet was formulated for each group based on grass hay, 
oats, and oriental mustard powder in the GSL groups. A small amount of liquid molasses was 
used to mix the oriental mustard powder into the concentrate. Table 3.1 shows the feed 
composition of the diets and the daily intake of nutrients. The mares had continuous access to 
trace mineral salt blocks (10:10 Agri-Blok, Canadian Agri-Blend Inc., 8702A 98th Street 
Morinville Industrial Park, Morinville, Alberta, Canada T8R 1K6) which contained 4800 mg/kg 
iron, 2500 mg/kg copper, 10,000 mg/kg zinc, 8000 mg/kg manganese, 30 mg/kg cobalt, 200 
mg/kg iodine, and 30 mg/kg selenium until the beginning of the feeding trial. The mares were 
trained to go to an individual bucket where they were tied up and fed their concentrate ration. 
Any residual feed left in the bucket was weighed back. The hay was weighed for the group, 
divided and fed in individual small diamond hay nets.  
At trial initiation, the oat ration was fed twice daily and increased gradually over a one-
week period until a total of 1.8 kg DM oats per day was reached. Mares in the Control group 
(n=6) were fed trace minerals and iodized salt to meet their minimal requirements for minerals as 
per NRC (2007). For the first 6 weeks, a similar percentage of OMP from the palatability trial 
was included in the concentrate of the GSL groups as follows: mares in the Low GSL group 
(n=7) received 110 g (5.8%) per day of OMP (12.5 mmol GSL), and mares in the High GSL 




level was increased to 160 g or 8.2% OMP (20 mmol GSL) in the Low GSL group and to 280 g 
or 13.5 % OMP (35 mmol GSL) in the High GSL group from 6 weeks until the end of the 
feeding trial. It is worth mentioning that a third attempt was performed to increase the mustard 
level to 25 and 50 mmol GSL in the Low and High GSL group, respectively; however, this 
resulted in the rejection of some or all of the concentrate mixture in 11/13 mares.  
 
3.3.4  Thyroid releasing hormone (TRH) response tests 
 
The TRH stimulation test was initiated between 8:30 am and 10:00 am on all mares at 
week 0 and 12 weeks. A baseline jugular sample was drawn followed by the intravenous 
administration of 1 mg of TRH (TRH, Sigma Aldrich Chemical Company, 2149 Winston Park 
Drive, Oakville, Ontario, Canada L6H 6JH).  Blood samples were then obtained using sterile 
tubes without anticoagulant at 45 minutes, 2 hrs and 4 hrs post TRH injection. Blood was 




The definition of the euthyroid state at the beginning of the trial was basal thyroid 
hormone levels within the basal adult reference range used by the Animal Health Diagnostic 
Center Endocrine Laboratory at Cornell University: TT4 (12.87 – 38.6 nmol/L), TT3 (0.408 – 
1.088 nmol/L), and for TSH the range reported by Breuhaus (2002) (0.03 – 0.97 ng/mL), or a 
response to TRH administration within the range reported by Breuhaus (2011) which for TT4 
was 1.3 – 3.8 fold increase over the Pre-TRH TT4 level at 4 hours Post-TRH administration or 
for TT3 was a 1.1 – 10.3 fold increase over the Pre-TRH TT3 level at 2 hours Post-TRH 
administration [19,111]. The definition of an ‘adequate response’ to TRH was a doubling of the 
TT4, TT3 and TSH concentrations compared to basal levels according to Breuhaus (2011) [19]. 
Fold change (FC) is the ratio of Post-TRH/basal hormone concentration at the same Post-TRH 









Thyroid hormones, total thyroxine (TT4) and total triiodothyronine (TT3) concentrations 
were assayed using the Immulite method (Siemens Immulite Canine TT4, and TT3, 1577 North 
Service Road East, Oakville, Ontario, Canada L6H 0H6) validated for use with equine serum at 
the Endocrine Laboratory, Prairie Diagnostic Services, Saskatoon, SK. The analytical sensitivity 
of the TT4 assay was 0.15 nmol/L.  Specificity data from the manufacturer identified 100% 
cross-reaction with L-thyroxine, 55% with D-thyroxine, 16% with tetraiodothyroacetic acid, and 
3.2% with triiodo-L-thyronine.  The intra-assay coefficients of variation for TT4 were 10.6%, 
6.4% and 5.2% for reference sera with a mean TT4 concentration of 10.55, 22.4 and 42.0 
mmol/L, respectively. The analytical sensitivity of the TT3 Immulite assay is 0.54 nmol/L. 
Specificity data from the manufacturer identified 100% cross-reaction with triiodo-L-thyronine, 
100% with triodo-D-thyronine, 1.3% with tetraiodothyroacetic acid, and 0.7% with 
triiodothyroacetic acid. The inter-assay coefficients of TT3 were 2.1%, 3.5% and 0.9% for 
reference sera with mean triiodothyronine concentrations of 1.1, 3.1 and 6.0 nmol/L, 
respectively. Laboratory personnel were blinded to the treatment group identity of the samples. 
Reference ranges for thyroid hormones in adult horses were obtained from the Animal Health 
Diagnostic Center Laboratory at Cornell University, Ithaca, NY, 148523, previously described in 
the Definition section. The concentrations of TT4 and TT3 were determined basal, at 2 hr after 
TRH injection for TT3 (2hr post-TRH) and at 4 hr after TRH injection for TT4 (4hr post-TRH).   
 
3.3.7  TSH  
 
The TSH assay was conducted by Donald L. Thompson at Louisiana State University, 
Baton Rouge, LA using a RIA assay validated for horses [153].  Briefly, TSH was measured by a 
double-antibody RIA based on anti-TSH antiserum (AFP-33812) and highly purified equine 
TSH (AFP-5144B) supplied by A. F. Parlow (National Hormone and Pituitary Program, Harbor-
UCLA Medical Centre, Torrance, CA) [153]. The intra-assay coefficient of variation was 6.0% 
and the inter-assay coefficient of variation was 7.2%. The lower and upper reference range for 
TSH used was 0.03 – 0.97 ng/mL, which is from Breuhaus (2002) for horses from three to 
nineteen years of age [111]. Thyroid stimulating hormone was measured in at baseline and 45-





3.3.8  Serum Iodine 
 
Serum iodine concentration was measured at the Animal Health Diagnostic Laboratory at 
University of Guelph, Guelph, ON, using an ICP-MS method in serum samples obtained at week 
0 and week 12 of the study. The detection limit of ICP-MS method for serum iodine was 4 µg/L. 
The reference ranges for serum iodine were <10 µg/L deficient, 11- 19 µg/L marginal, 20 - 49 
µg/L adequate, >50 µg/L high. Reference ranges were based on the published values from Puls 
(1994) [41] and Mochizuki et al. 2016 [8]. An ‘adequate’ serum iodine level was defined as a 
serum iodine level at or above the low end of the healthy adult reference range (20 µg/L) [41].   
 
3.3.9  General Data Analysis 
 
For all tests, data were considered statistically significant if P <0.05. The TT4, TT3, 
TSH, and iodine data were analysed for normality (Shapiro-Wilk test), Kruskal-Wallis, 
Wilcoxon pairs test, and Fisher’s Exact Tests using proprietary software (StatPlus 2, Analyst 
Soft, 340 South Lemon Ave. #3010, Walnut, California, USA 91789). Descriptive data is 
reported by Group for TT4 [mean ± SD (range)], and TT3, TSH and iodine [median (quartiles)] 
at week 0 and week 12.  Changes in mare weight from week 0 to week 12 were evaluated using a 
Wilcoxon Pairs Test. Comparisons were made within groups using Kruskal-Wallis to examine 
the change in serum iodine from week 0 to week 12. A generalized estimating equation analysis 
(GEE) was performed for the three hormones (TT4, TT3 and TSH) and iodine concentrations 
using proprietary software (SPSS version 24a, IBM, 1 New Orchard Road, Armonk, New York, 
USA 10504-1722). The main effects in the GEE model were ‘Week’ (week 0 and week 12) and 
‘Group’ (three treatments; Control, Low GSL and High GSL) and interaction between “Week” 
and “Group” variables were included in the model. Comparisons between Groups were made at 
each time point and changes over time within the same group were evaluated. Parameters 
examined for each hormone (TT4, TT3, and TSH) using the GEE included: basal level, post-
TRH administration level and FC. The post hoc analysis was the Least Significant Difference 
(LSD) which included pairwise comparisons of the groups between and within each time points.  
Serum iodine concentrations at week 0 and week 12 were compared with Group and Week as 





Comparisons were made between the proportion of mares in each group at week 0 and week 
12 in basal TT4, TT3, TSH and serum iodine concentration in the normal reference range (at or 
above the lowest value of the respective adult reference range); and comparisons were made 
between the proportions of mares with an ‘adequate response’ i.e. two-fold or greater increase 
from the baseline TT4, TT3 and TSH level to the 4hr TT4, 2hr TT3, and 45 min TSH level 
respectively, using Fisher’s Exact Tests. 
 
3.4 Results  
3.4.1  General 
 
All mares were considered to be healthy at the initiation of the trial based on physical 
examination findings. The mares were determined to be euthyroid based on basal TT4 and TT3 
concentrations or an increase after the TRH injection at 4hr TT4 and 2hr TT3, which were within 
the reference range for each hormone [19]. We found at week 0 that 3/19 mares did not have a 
minimum FC of 1.1 in the 2hr TT3 level and 1/19 mares did not have a minimum FC of 1.3 for 
the 4hr TT4 level; however these mares had high basal levels that were within the normal 
reference range for TT3 and TT4. There were 18/19 mares with serum iodine level in the 
reference range at week 0, and one mare in the Control group had a serum iodine concentration 
of 19 µg/L, which was close to the low reference range value for healthy horses of 20 µg/L 
[111]. There were no significant changes in the mares’ weights from week 0 to week 12. 
According to the corresponding type of feed of each group, feed consumption was the same 
between control and GSL groups during the feeding trial.  
 
3.4.2  TT4 
 
There were no differences (mean nmol/L ± SD) in basal TT4 concentrations at week 0: 
Control (22.6 ± 4.0); Low GSL (27.2 ± 6.8); High GSL (23.6 ± 5.4); but there was a significant 
effect of Week (P = 0.022) with lower basal TT4 values by week 12 found in Control (20.8 ± 
9.4); Low GSL (23.2 ± 8.0); and High GSL (20.8 ± 4.2) mares. Regarding post-TRH TT4 
concentrations, there was an effect of Group and Week (P < 0.001). The post-TRH TT4 




to: week 0 Control (35.1 ± 9.2) (P <0.001), week 12 Low GSL (31.7 ± 10.9) (P = 0.025) and 
week 12 High GSL (25.8 ± 2.5) (P <0.001); but there were no differences at week 0 between 
Control, Low GSL (35.7 ± 8.5) and High GSL (35.4 ± 8.5) groups.  
There was a significant Group (P <0.001) and Group and Week interaction (P <0.001) in 
TT4 FC [median nmol/L ± median standard error (SE) (quartiles)], with week 12 Control group 
[2.2 ± 0.1 (1.8, 2.7)] values higher than all other groups as follows: Control week 0 [1.6 ± 0.05 
(1.4, 1.7)] (P <0.001), week 12 Low GSL [1.3 ± 0.03 (1.2, 1.4)]  (P <0.001) and week 12 High 
GSL [1.2 ± 0.04  (1.1, 1.4)] (P <0.001); week 0 Low GSL [1.4 ± 0.06 (1.1, 1.4)] (P < 0.001) and 
week 0 High GSL [1.5 ± 0.1 (1.3, 1.7)] (P=0.006). The scatter plots for the basal TT4, Post-TRH 
TT4 and TT4FC data at week 0 and week 12 are shown in Figure 3.1 to 3.3.  
 
3.4.3  TT3 
 
There were no differences [median nmol/L ± SE (quartiles)] in basal TT3 concentrations at 
week 0: Control  [1.0 ± 0.1 (0.6, 1.4)]; Low GSL [1.2 ± 0.1 (0.8, 1.6)]; High GSL [0.5 ± 0.2 (0.4, 
0.9)]; and at week 12: Control  [1.5 ± 0.3 (1.2, 1.7)], Low GSL [1.1 ± 0.1 (0.9, 1.3)] and High 
GSL [1.3 ± 0.1 (1.0, 1.4)] groups. Regarding the post-TRH TT3 concentrations there was an effect 
of Group (P = 0.001) and a Group by Week interaction (P = 0.001). There were higher post-TRH 
TT3 concentrations in week 12 Control [median nmol/L ± SE (quartiles)] [6.61 ± 0.4 (5.6, 7.6)] 
versus: week 0 Control [2.1 ± 0.2 (1.6, 3.1)] (P <0.001), week 0 Low GSL [1.8 ± 0.2 (1.3, 3.2)] (P 
<0.001);  week 12 Low GSL [1.82 ± 0.2 (1.5, 2.6)] (P <0.001) and week 12 High GSL [1.83 ± 0.1 
(1.6, 2.1)] (P <0.001); with no effect on the week 0 High GSL group [2.5 ± 0.7 (2.4, 6.3)].  
Regarding TT3 FC there was an effect of Group (P = 0.018) and Group and Week interaction (P = 
0.023). The week 12 Control group [median ± SE (quartiles)] FC [4.1± 0.6 (2, 6.2)] was greater 
than the week 12 Low GSL FC [1.6 ± 0.1 (1.5, 1.8)] (P = 0.02); week 12 High GSL FC [1.5 ± 0.1 
(1.1, 1.7)] (P <0.01); and week 0 Low GSL FC  [2.1 ± 0.1 (1.1, 1.5)] (P = 0.028) with no 
difference for week 0 Control FC [2.6 ± 0.4 (1.7, 3.5)], and week 0 High GSL FC [5.6 ±  1.5 (3.1, 
8.9)].  
 





There were no differences between weeks or groups in TSH for basal, 45-minute post-TRH or 
FC. Table 3.2 shows the [median ng/mL ± SE (quartiles)] TSH concentrations in basal, post-TRH 
and FC values at week 0 and week 12.  
 
3.4.5  Serum Iodine 
 
Serum iodine concentrations [median µg/L ± SE (quartiles)] at week 0 versus week 12 were: 
Control [23.5 ± 0.8 (22.25, 0.85) versus 37.5 ± 1.2 (29.5, 44.0)]; Low GSL [26 ± 0.7 (23.5, 27.5) 
versus 15 ± 0.8 (14.5, 20)] and High GSL[ 22 ± 0.6 (21.25, 25) versus 16.5 ± 0.4 (14.5, 17.8)]. 
There was a significant effect of Group (P < 0.001) and a Group by Week interaction (P < 0.001) 
on iodine concentrations. Control mare serum iodine concentrations had a positive change from 
week 0 to week 12, and by week 12 control mare concentrations were higher than all other groups 
(P < 0.002) at all time points. Low and High GSL Group’s serum iodine concentrations had a 
negative change from week 0 to week 12 with the change (week 0-week 12) [median µg/L ± SE 
(quartiles)] in serum iodine concentrations as follows: Control [-11.5 ± 1.9 (-21.0, -5.0)]; Low 
GSL [9.0 ± 9 (8.0, 10.0)]; and High GSL [7.5 ±  0.4 (8.0, 5.5)].  
 
3.4.6  Fisher’s Exact test:   
 
A comparison of the proportion of mares with adequate basal TT4, TT3, and TSH was 
statistically similar at week 0 between groups. A comparison of the proportion of mares in a group 
that achieved an adequate TT4 response (doubling of basal TT4 concentration by post-TRH) at 12 
weeks was different (P = 0.004), and included 4/6 Control, 0/7 Low GSL, and 0/6 High GSL 
mares. A comparison of the proportion of mares in a group with a doubling of their basal TSH 
value at post-TRH at week 0 versus 12 was: Control 5/6 versus 1/6; Low GSL 4/7 versus 6/7; and 
High GSL 6/6 versus 3/6, respectively, with P = 0.055. Regarding serum iodine concentrations, a 
comparison of the proportion of mares in a group at week 0 having serum iodine concentrations in 
the reference range were not different with 5/6 control mares, 7/7 Low GSL mares and 6/6 High 
GSL mares having adequate levels. At week 12 there was a difference (P = 0.0005) in the 
proportion of mares with iodine concentrations in the reference range with 6/6 Control mares, 2/7 




3.5  Discussion   
The goal of the study was to create conditions such as a low dietary iodine and GSL 
exposure, which are reported to be risk factors for mares that deliver foals with congenital 
hypothyroidism and determine the effects on serum iodine and thyroid hormones concentrations 
[6,118,147]. We partially accept our hypothesis, as our study showed that feeding a low iodine 
diet in combination with the GSL sinigrin at 20 and 35 mmol/day for 12 weeks to non-pregnant 
mares had no effect on body weight, but lowered serum iodine concentrations and affected the 
thyroid secretion of TT4 in response to TRH administration with no effect on TT3 compared to 
Control group; however, FC TT4 was not different between High and Low GSL groups. It is 
worth mentioning that due to the study design, we are unable to draw final conclusions as to the 
relative contribution of low iodine supplementation versus the addition of GSL to the diet. This 
study would have been strengthened by the addition of a Control group without sinigrin, and a 
GSL group with iodine supplementation; however due to financial constraints this was not 
performed. Nevertheless, the combination of low dietary iodine and GSL may have negative 
effects on pregnant mares and neonates because of the essential role of thyroid hormones and 
iodine during embryonic, fetal and early life development based on studies performed in other 
domestic animals, such as goats, but requires further study.  
The amount of GSL fed in this study (35 mmol/day) could be easily consumed by a horse 
as 12.2 mg GSL /g dry weight of whole wild mustard seed has been reported and over 130 µmol/g 
of cultivated oil seed [154,155]. Canola meal (Brassica napus), a variety of plant selected for low 
GSL content, has been widely used in rations for dairy and beef cattle, swine, poultry and fish 
production due to the high protein quality [66]. Cymbaluk (1990), Oliviera et al, (2001) reported 
feeding different levels of canola meal in growing foals with no adverse effects, such as decrease 
feed intake and delayed in growth rate, in a 60 - 75-day period [141,142]. This suggests that 
similar to our study, relatively short periods of GSL feeding to horses do not affect health in terms 
of weight. The cost benefit of adding various GSL containing ingredients to equine feeds has not 
been determined, as the tolerance to different GSL have not been fully described. It is worth 
mentioning that content and composition of GSL varies by plant species and is affected by 
climatic conditions, thus, the GSL type and content from the same plant species may be different 
every year. Experimentally this means GSL content in feed ingredients must be analyzed. In the 




selective eaters, and decreased intake or feed refusal may occur with high amounts of GSL in the 
diet [66]. Our initial objective was to increase the feeding of the GSL sinigrin contained in the 
OMP (Brassica juncea) to 50 mmol GSL per day for the Low GSL group and 100 mmol GSL per 
day for the High GSL group, which was based on previous reports in cattle, where it was reported 
that a concentration of 100 mmol GSL was able to induce thyroid dysfunction [66]. Nonetheless, 
an increase in the amount of OMP more than 35 mmol sinigrin per day lead to a decrease in the 
voluntary intake and rejection of the concentrate mixture in the majority of the GSL mares; 
however, one mare in each of the Low GSL and High GSL groups tolerated the higher 
concentration, suggesting that under natural conditions individual variability in voluntary intake 
and tolerance for GSL may make some horses more likely to consume mustard plants than others. 
Furthermore, a concentration of 20 – 35 mmol/day of sinigrin was adequately tolerated by the 
Low and High GSL groups, respectively, until the end of the feeding trial and there was no change 
in feed consumption.  
There is little information regarding the tolerance to and effects of sinigrin, which is 
metabolized to isothiocyanates, and nitriles, on equine thyroid hormone function. Isothiocyanates 
have been reported to reduce the thyroid’s ability to take up iodine, synthesize thyroid hormone, 
and release thyroid hormones [112,132]. We report that sinigrin at the level fed in this study 
combined with low dietary iodine conditions influences the thyroid response to TRH. In this study 
there was a failure in both GSL groups to respond adequately to TRH stimulation as shown by a 
lower TT4 and TT3 FC, compared to Control group mares at week 12 in spite of having similar 
Post-TRH TSH levels. Figure 1 shows there is very little dispersion of the T4 data in the GSL 
groups. The higher response by Control mares at week 12 may be attributed to seasonal factors, 
but this would be in contrast to the findings of other research groups that concluded there was no 
effect of season on TRH response in horses [25,156]. Due to the small group size in this study and 
our experimental design we cannot be certain if the increase in Control Group mare’s response to 
the TRH stimulation test was due to chance, a seasonal effect, a result of the iodine supplemented 
diet in the 12-week period, an interaction between factors or due to a combination of factors.  
Other authors have reported seasonal changes in basal secretion of TT4 [30,33,152].  
Fazio et al. (2016) reported intrinsic seasonal changes in thyroid hormone synthesis in 
pregnant and non-pregnant mares in basal TT3 and TT4 [30]. Johnson (1986) reported highest 




high through December to May and lower from July to October [33]. There are a variety of 
extrinsic factors that influence thyroid hormones synthesis such as: age, sex, feed deprivation, 
diets containing high energy and protein content, stress, trace minerals, and treatment with 
medications such as phenylbutazone and corticosteroids [1,19,25,35,112]. One study in a region 
known for endemic goiter in human and domestic animals showed that adult horses without 
supplementation of iodine and no exposure to Brassica plants had basal TT4 levels higher than 
horses in the non-endemic area and were without clinical signs of hypothyroidism [27]. The 
authors concluded that the horses in this region were resilient and had developed compensatory 
mechanisms for low environmental iodine and were not hypothyroid [27]. Another author reported 
that foals with goiters and mares on the same farm had low TT4 but TT3 levels were within the 
normal range in an area with iodine deficient soil [108]. Medica et al. (2011) reported that under 
similar environmental, management, and nutritional conditions that pregnancy status in mares 
played a dynamic role on thyroid hormone patterns and may be very important in early embryonic 
growth and development [27]. Indicating that substances such as GSL that may alter maternal 
thyroid function should be avoided throughout pregnancy in mares.  
Regarding TSH, the basal and Post TRH TSH concentrations were not significantly 
different compared to Control mares, indicating that pituitary function was adequate and the lack 
of change in the Pre-TRH TSH level indicates that primary hypothyroidism was not induced after 
a three-month exposure to sinigrin. In cases of primary hypothyroidism, basal TSH and post TRH 
responses are dramatically increased [19]. However, in horses, primary hypothyroidism has only 
been achieved experimentally by the administration of highly purified propylthiouracil (PTU), a 
well-known synthetic goitrogen used in human medicine to treat hyperthyroidism. The 
administration of PTU has been used to induce experimental hypothyroidism in rats, cattle, sheep 
and horses [66,150]. We concluded that sinigrin when fed for 12 weeks in this study along with a 
low iodine diet affected thyroid function, because of the effect on the Post TRH response at week 
12 in the GSL groups. A diet formulated with a higher amount of sinigrin, or a more potent 
goitrogenic GSL compound fed for a longer period of time, along with a diet deficient or low in 
iodine would likely be required, to induce primary hypothyroidism. Other GSL whose metabolites 
are much more potently goitrogenic, may induce changes in TSH concentrations in a shorter 




It has been reported in other farm animals that chronic exposure to secondary metabolites 
of GSL such as isothiocyanates, thiocyanates and oxazolidithione decreases iodine uptake by the 
thyroid thus causing thyroid dysfunction [66]. There are species differences in their sensitivity to 
the effects of GSL. In cows and pigs, a concentration between 10 to 11 mmol/kg GSL of the diet 
can induce iodine deficiency, whereas in the sheep a concentration ≥ 4.22 mmol/kg GSL of the 
diet causes iodine deficiency in pregnant ewes and affects thyroid weight and thyroid histology in 
newborn lambs [150]. The prevalence of goitre and thyroid insufficiency in newborn lambs was 
reported in pregnant ewes fed different Brassica family plants (rye grass, radish, and rape) with or 
without iodine supplementation [66,150]. The ewes fed radish forage (total GSL per diet: 3.0 
mmol/kg, mainly glucobrassicin) and rape (total GSL per diet: 7.45mmol/kg, mainly progoitrin) 
failed to respond adequately to a TRH stimulation test [150]. The lambs born to ewes fed rape 
without iodine supplementation resulted in a higher incidence of goitre compared to ewes fed 
radish forage, and both groups had decreased TT4 following administration of TRH [150]. The 
results of this particular study in sheep were used to justify why no additional iodine was added to 
the mares in the GSL diet groups, as the threshold for protection from the effects of GSL by iodine 
supplementation in horses is not known [66]. The findings of this study showed that the type, and 
concentration of GSL, along with iodine supplementation all play a key role in the development of 
fetal goitres during pregnancy in sheep, and illustrated that in cases with no evident goitres, 
thyroid hormone synthesis is still affected [150].  
Serum iodine concentrations decreased a median of 9 µg/L in the Low GSL group, and 7.5 
µg/L in the High GSL group by week 12.  The result was a decrease in serum iodine from the 
normal to the marginal range according to Puls (1994) in 5/7 mares in the Low GSL group and 6/6 
mares in the High GSL group [41]. The week 0 serum iodine levels of 18/19 mares were within 
the reference range reported by Puls (1994) [41]. This was interpreted to mean that there was no 
pre-existing iodine deficiency in the mares based on these values. As the groups were not different 
in iodine levels at week 0, we concluded that the decrease in iodine was a reflection of the 
combined effect of the GSL, and the non-iodine supplemented diet, which then resulted in an 
impaired response to TRH. The GSL group diets were low in iodine content but were not iodine 
free. The NRC requirement for iodine in mature horses whose mean weight is 464 kg is 3.2 mg 
day. Based on the values reported in Equine Clinical Nutrition (2013) for iodine content in hay 




in the range of 1.6 – 3.3 mg of iodine (50% to 103% of the recommended value) [35]. A non-
iodine supplemented diet for 12 weeks was deemed unlikely to produce this effect on the thyroid 
response to the TRH alone; however the experimental design does not allow us to draw firm 
conclusions in this regard [150].  
There are no studies addressing the effect of iodine supplementation on thyroid 
responsiveness in horses; however in euthyroid human patients, high iodine supplementation 
decreases TT4 and TT3 and mildly increases TSH [157]. The Control mare’s serum iodine values 
were maintained within the reference range for healthy horses at both time points [41]. Studies in 
humans have shown that iodine supplementation to euthyroid people twice the recommended daily 
intake for a 2-month period did not modify thyroid function by increasing or decreasing basal 
levels of free TT4 and TT3 [157]. Excess iodine supplementation can result in a reduction in 
thyroid hormone synthesis through a regulatory mechanism in which there is a temporally 
protection against an excessive production of TT3 and TT4 when the thyroid gland is exposed to a 
sudden large amount of iodine [157]. 
The sensitivity to the effects of GSL by adult horses compared to equine fetuses is 
unknown. The demonstration that GSL suppressed serum iodine in non-pregnant mares likely 
means that dietary GSL would affect pregnant mares and may also impair embryonic development 
and fetal thyroid function. The GSL metabolites have been reported to cross the placenta and 
affect fetal thyroid function in many species; however, future research should be performed to 














Table 3.1: Ingredient and nutrient composition of diet groups based on dry matter: Control, Low 
and High glucosinolate (GSL) (upper) and nutrient composition and daily intake of the mares 
(lower). 
 
Ingredient and Nutrient Composition of Diets Fed to Non-Pregnant Mares 
Ingredient Intake 
(daily)  
Control Low GSL High GSL 
Wk 0 - 12   Wk 0 - 6 Wk 6 - 12 Wk 0 - 6 Wk 6 - 12 
Mixed Grass Hay kg 7.14  7.14 7.14 7.14 7.14 
Oats kg 1.78 1.78 1.78 1.78 1.78 
Mustard Meal 
Powder 
gm - 110 160 220 280 
Molasses, beet sugar ml 20 160 160 200 200 
Weathergard 22 gm 50 - - - - 
Iodized salt gm 25 - - - - 
 
Nutrient Composition (daily intake) 
   Control Low GSL High GSL 
Nutrient Amount  NRC*  Wk 0 - 12   Wk 0 - 6 Wk 6 -12 Wk 0 - 6 Wk 6 - 12 
Digestible 
energy  
Mcal 16.65 18.79 19.29 19.29 19.42 19.42 
Crude protein gm 630 994 1046 1065 1091 1113 
Calcium gm 20 58 50 50 50 51 
Phosphorus gm 14 21 17 17 18 19 
Selenium mg 1.0 1.3 0.8 0.8 0.8 0.8 
Iodine mg 3.5 6.6 0.3 0.3 0.3 0.3 






Table 3.2: Serum TSH concentrations (ng/ml) [median ± SE (quartiles)] levels in basal, 45- 
minute post-TRH samples and the Fold Change (Post-TRH divided by Pre-TRH level) in: 
























TSH Week 0 
Group Pre-TRH Post-TRH FC 
Control 0.7 ± 0.12 
(0.2 - .97) 
1.66 ± .49 
(0.6 – 3.4) 
3.1 ± 0.2 
(3.1 – 3.2) 
Low 
GSL 
0.6 ± 0.1 
(0.2 – 1.24) 
1.96 ± 0.4 
(0.6 – 3.1) 
2.5 ± 0.8 
(1.6 – 3.04) 
High 
GSL 
0.48 ± 0.1 
(0.06 – 0.7) 
1.5 ± 0.23 
(0.5 – 2.2) 
4.0 ± 0.5 
(2.7 – 5.2) 
 Week 12 
Group Pre-TRH Post-TRH  FC 
Control 0.57 ± 0.14 
(0.50 – 1.38) 
1.01 ± 0.29 
(0.71 – 2.34) 
1.2 ± 0.1 
(1.7 – 1.9) 
Low 
GSL  
0.5 ± 0.05 
(0.4 – 0.8) 
1.15 ± 0.3 
(0.9 – 3.2) 
2.5 ± 0.1 




(0.3 – 0.6) 
1.2 ± 0.31 
(0.2 – 2.4) 
2.2 ± 0.2 

















Figure 3.1. Scatter plot of serum total thyroxine (TT4) (nmol/L) concentrations in Control, Low 
and High glucosinolate (GSL) groups in: 1a) Basal TT4 concentrations at week 0; 1b) Basal TT4 
concentrations at week 12. The long horizontal line represents the mean and short horizontal 































































Figure 3.2. Scatter plot of serum total thyroxine (TT4) (nmol/L) concentrations in Control, Low 
and High glucosinolate (GSL) groups showing: 2a) the Delta in TT4 concentrations at week 0; 
and 2b) at week 12. The long horizontal line represents the mean and short horizontal lines the 
SEM. Upper case letters represent differences between groups over time and lower case letters 




































































Figure 3.3. Scatter plot of serum total thyroxine (TT4) (nmol/L) concentrations in Control, Low 
and High glucosinolate (GSL) groups in: 3a) TT4 Fold Change at week 0; 3b) TT4 Fold Change 
at week 12. The long horizontal line represents the mean and short horizontal lines the SEM. 
Upper case letters represent differences between groups over time and lower case letters 
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This chapter concerns the characterization of colostrum, milk and serum iodine levels in healthy 
post-partum mares and foals. The effect of an inadequate iodine supplementation in the diet 
during pregnancy is still unknown due to the lack of robust information regarding normal iodine 
reference values in foals’ serum, as well as milk and colostrum samples from post-partum mares. 
Mares in the study received free choice iodine supplementation during pregnancy and post-
partum. Iodine in serum, colostrum and milk were obtained between one to four hours post-
foaling (day 0) and ten days later. The values were compared with thyroid hormone 
concentrations. In species with an epitheliochorial placentation, such as the horse, maternal 
thyroid hormone transfer to the late term fetus is believed to be minimal, if any. For that reason, 
maternal iodine transfer to fetal circulation is essential for normal fetal thyroid hormone 
synthesis.  
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4.1 Abstract   
Iodine, thyroxine (T4) and triiodothyronine (T3) are required for normal fetal growth, 
maturation and neonatal survival. There is a lack of robust information on iodine levels found in 
colostrum, milk and serum of mares and foals following a healthy pregnancy. Our objective was 
to characterize colostrum, milk and serum iodine levels in healthy post-partum mares and foals 
(n = 10) and explore relationships with thyroid hormone concentrations. Colostrum, milk and 
jugular blood samples from draft breed mares and foals with an estimated average iodine daily 
intake of 39 mg per mare during pregnancy were obtained at day 0 (foaling date) and/or 10 days 
later. Parameters studied were: mare basal concentrations of serum: TT3, TT4, iodine; iodine in 
colostrum at day 0 and milk iodine (day 10); foal basal TT3, TT4 and serum iodine (day 0 and 
10). Median ± median error colostrum iodine levels (165 ± 15.1 µg/L) were higher than milk (48 
± 5.6 µg/L) (P =.007) levels. Median ± median error foal serum iodine (268.5 ± 7.6 µg/L), TT4 
(1225 ± 47.8 nmol/L) and TT3 (14.2 ± 1.1 nmol/L) at foaling date were higher than at 10 days 
(70 ± 3.6 µg/L; 69.6. ± 20.4 nmol/L; 5.4 ± 0.3 nmol/L, respectively). In conclusion, equine 
mammary tissue concentrates iodine beyond plasma levels, making colostrum and milk a 
significant source of iodine. Foal serum iodine levels are high in the neonatal period, and are 
positively correlated with TT4, which is important for neonatal adaptation.   
 
4.2  Introduction  
In all mammalian species, adequate levels of iodine are required to support synthesis of 
thyroid hormones such as thyroxine (T4) and triiodothyronine (T3), which are critical for normal 
intrauterine growth and fetal maturation [24]. Thyroid hormones are also involved in neonatal 
physiological processes, such as thermogenesis, and are essential for extrauterine life [11]. The 
epitheliochorial placenta of some domestic animals, such as sheep and horses, is reported to be 
impermeable to maternal thyroid hormones after the second trimester of pregnancy [21]. 
Nonetheless, iodide transfer from the maternal to fetal circulation through the placenta is 
necessary for active fetal thyroid hormone synthesis [11]. There is a lack of robust information 
on iodine levels found in mare colostrum, milk and serum of mares and foals, and little 
understanding of how iodine levels relate to thyroid hormone concentrations. Furthermore, while 




newborn foal, it has not been determined if mare colostrum is a source of iodine [158]. Puls 
(1994) reported that an adequate concentration of iodine in mare’s milk is between 10 to 16 ug/L 
[41], whereas, milk iodine levels between 4 to 42 ug/L have also been reported [159]. To our 
knowledge there is little information regarding iodine levels in equine colostrum versus milk 
along with serum iodine concentrations in neonatal foals. The aim of the study was to describe 
levels of iodine in serum, colostrum and milk samples in relationship to thyroid hormone 
concentrations from mares and their foals following a healthy pregnancy. Information regarding 
iodine concentrations in equine serum, colostrum and milk is needed for good nutritional 
management and will assist in the detection of trace mineral deficiencies, which affect the 
development of the equine neonate. 
4.3  Material and Methods  
4.3.1  Mare Management  
 
The present study was approved by the University of Saskatchewan’s Institutional 
Animal Care and Use Committee. Healthy Clydesdale mares (n=10) ranging from 5 to 13 years 
with a mean age of 8.9 ± 2.7 years were bred by live cover. Mares had access to timothy 
grass/alfalfa hay in large round bales ad libitum for the entire pregnancy. The average weight of 
the mares was 680 kilograms (kg). Mares had free access to a combination of a commercial 
granulated equine vitamin and mineral supplement (Masterfeeds, 1020 Hargrieve Road London, 
Ontario, Canada N6E1P5) mixed with 150 mg/kg iodized salt (Ceres Industries, Site 603, Box 10 
RR#6 Saskatoon, SK, Canada S7K3J9) at a ratio of 1:1, respectively. A 20 kg cobalt iodized salt 
block (iodine: 200 mg/kg; cobalt: 100 mg/kg, Ceres Industries, Site 603, Saskatoon, SK S7K3J9) 
was placed in the pen every month until foaling. In addition, all mares were group-fed 
approximately 5.1 kg dry matter (DM) oats once per week per mare (the equivalent of 0.73 kg 
oats DM/day), during pregnancy. All mares foaled uneventfully at term with a mean ± SD 
gestational length of 343 ± 11.1 days. Foals were bottle fed with 1.2 L of colostrum in divided 
feedings before 4 hrs post foaling, unless they were found already nursing and they were then 
bottle fed 600 mL of colostrum. Table 4.1 shows the manufacturer’s guaranteed analysis of the 
vitamin and mineral content of the commercial granulated equine vitamin and mineral 




Mare and foal (n=10) jugular blood samples (10 mL) were taken on day 0 (foaling date), 
and 10 days later using sterile tubes without anticoagulant. Regarding day 0 foal blood samples, 
all blood samples were taken after the foal received colostrum or was found nursing; six out of 
ten foals’ serum samples were obtained within one-hour post-foaling, whereas, the remaining 
blood samples were obtained at approximately 4 hrs after birth. Serum samples were refrigerated 
overnight, centrifuged, serum removed and frozen at -20ºC. Colostrum samples were obtained 
between one to four hours after birth and were tested for quality using a Brix sugar refractometer 
(Animal Reproduction Systems, Inc, Chino, CA, USA), the reference ranges used were: 10-15 % 
Brix: 0-28 g/L IgG content or poor quality; 15-20 % Brix: 28-50 g/L IgG content or borderline 
quality; 20-30 % Brix: 50-80 g/L IgG content or adequate quality, and >30 % Brix: >80 g/L IgG 
content or very good quality. Milk samples were obtained by milking one side of the udder while 
the foal was suckling the other side at 10 days post-foaling. Colostrum and milk samples were 
stored in 50 mL plastic tubes and frozen at -20ºC until analysis.  
 
4.3.2  Serum, colostrum and milk iodine  
 
Serum from mares (day 0) and foals (day 0 and 10) plus 30 mL of colostrum (day 0) and 
milk were submitted to the Animal Health Diagnostic Laboratory at University of Guelph, 
Guelph, ON, for iodine analysis using inductively coupled plasma mass spectrometry (ICP-MS). 
The detection limit of ICP-MS method for serum, colostrum and milk iodine was 4 µg/L. The 
reference ranges used were according to Puls (1994) [41] and Mochizuki et al. (2016) [8].  The 
adult horse serum iodine ranges were: <10 µg/L deficient, 11- 20 µg/L marginal, 21 - 49 µg/L 
adequate, >50 µg/L high, and for milk iodine were: <4 µg/L deficient, 10 – 16 µg/L adequate, 
and 50 µg/L toxic [41].  
 
4.3.3  Thyroid hormones 
 
Basal thyroid hormone levels of total thyroxine (TT4), and total tri-iodothyronine (TT3) 
from mares and foals were determined at day 0 and day 10 using the Siemen’s Immulite TT4 and 
TT3 kits (Siemens Immulite Canine TT4, and TT3, 1577 North Service Road East, Oakville, 
Ontario, Canada L6H 0H6) validated for use with equine serum at the Endocrine Laboratory, 




nmol/L.  Specificity data regarding the anti-TT4 antibody from the manufacturer identified 100% 
cross-reactivity with L-thyroxine, 55% with D-thyroxine, 16% with tetraiodothyroacetic acid, 
and 3.2% with triiodo-L-thyronine. The intra-assay coefficients of variation for TT4 were 10.8%, 
11%, 13.4% and 8.8% for reference sera with a mean TT4 concentration of 63.9, 119, 10.8 and 
21.8 mmol/L, respectively. The analytical sensitivity of the TT3 Immulite assay is 0.54 nmol/L. 
Specificity data from the manufacturer regarding the anti-TT3 antibody identified 100% cross-
reaction with triiodo-L-thyronine, 100% with triodo-D-thyronine, 1.3% with tetraiodothyroacetic 
acid, and 0.7% with triiodothyroacetic acid. The inter-assay coefficients of TT3 were 7.6%, 
6.3%, 9.1%, and 3.2% for reference sera with mean TT3 concentrations of 0.7, 1.1, 3.3, 5.8 
nmol/L, respectively. Laboratory personnel were blinded to the identity of the samples. 
Reference ranges for thyroid hormones in adult horses were obtained from the Animal Health 
Diagnostic Center Laboratory at Cornell University, Ithaca, NY, 148523. The lower and upper 
end of the reference range for TT4 is 12.87 - 38.6 nmol/L and for TT3 is 0.46 - 1.088 nmol/L. 
The mare and foal TT4/TT3 ratios were calculated.  
 
4.3.4  General Data Analysis 
  
All data were analyzed for significance at P<0.05. Proprietary software (SPSS version 
24a, IBM, 1 New Orchard Road, Armonk, New York, USA 10504-1722) was used for statistical 
analyses. The data were evaluated for normality and Spearman rank correlations were performed 
between foal and mare parameters at day 0 and 10, and between foal serum iodine and thyroid 
hormone levels. Wilcoxon signed rank test was used to determine the difference in thyroid 
hormones, serum, milk and colostrum iodine concentrations between mares and foals on the day 
of foaling, and from day 0 to day 10 in foals.  
 
4.4  Results  
One foal died of an unknown cause at 10 days of age, and therefore no day 10 serum 
sample was obtained. Serum from one mare was lost in shipment. Based on reference ranges 
according to Geor (2013), the mares consuming 2.5% of their body weight in kilograms DM 




ration (timothy grass hay plus oats) was estimated at 3.1 mg iodine per day [160]. The iodized 
salt, vitamin mineral supplement, and cobalt salt intake based on the amount fed and the 
manufacturer’s guaranteed analysis was estimated to provide an additional 35.8 mg iodine per 
mare per day, for a total of 39 mg iodine or 2.2 mg iodine / kg DM. It was noted that there was 
variable intake among mares, as some mares were more frequently seen consuming the 
vitamin/mineral/salt mixture. 
 
4.4.1 Colostrum quality 
 
Based on the sugar refractometer (Brix % type): 5/10 colostrum samples had adequate 
colostrum quality (20-30 % Brix or 50-80 g/L of IgG content), 3/10 colostrum samples had 
borderline colostrum quality (15-20 % Brix or 28-50 g/L of IgG content) and 2 samples were not 
analysed due to laboratory oversight.  
 
4.4.2  Serum, colostrum, milk iodine  
 
Foal serum iodine values are shown in Table 4.2. Foal iodine concentrations were 14.1 
times higher (P =.001) than mare levels at birth; and median foal serum iodine levels decreased 
(P =.012) 3.8-fold from birth to day 10. Colostrum iodine levels were 3.4-fold higher (P =.007) 
than day 10 milk levels [48 ± 5.6 (31.7, 62)]. Foal serum iodine at foaling date (day 0) and day 
10 showed a strong positive correlation with basal TT4 concentrations (r = 0.930, P =.001; r = 
0.952, P =.001, respectively). Figure 4.1 shows the relationship between colostrum and milk 
values for each mare. Figure 4.2 shows the change in each foal’s serum iodine level from day 0 
to day 10. 
 
 
4.4.3 Thyroid Hormones 
 
Foal TT4 levels are shown in Table 4.2. Foal serum TT4 concentrations were 65.9-fold 
higher (P =.005) than mare levels on day 0, whereas, foal TT3 levels were 14.5 fold higher (P 
=.005) than mare TT3 levels on day 0. In addition, foal TT4 decreased (P =.008) 17.6-fold from 




milk and serum iodine and TT4 and TT3 data are also summarized in Table 4.2. Figure 4.3 
shows the change in foal TT4 from day 0 to day 10. 
4.4.4 TT4/TT3 Ratio 
 
The TT4/TT3 ratio was calculated and data are presented in Table 4.2. At day 0 foal 
TT4/TT3 ratio (85.9:1) was higher (P =.005) than the mare ratio (16.1). The foal day 10 
TT4/TT3 ratio (15.4:1) was lower and different (P =.008) than at day 0. The foal median day 10 
TT4/TT3 ratio (15.4:1) was not different from the day 0 mare TT4/TT3 ratio (16.1:1).  
4.5  Discussion  
Iodine deficiency is one of the top three most prevalent nutritional deficiencies 
worldwide [8]. Iodine is an essential nutrient needed for thyroid function, growth and 
metabolism [8,24]. The relationship between iodine status and thyroid function is not well 
described in horses, as direct investigation into iodine concentrations in horses was previously 
impossible due to a lack of laboratory capacity [8]. The central role of thyroid function and the 
long-term consequences on processes such as epigenetic programming have been described in 
pregnant mares [1].  
This is the first paper that describes the rapid change in serum iodine levels in foals after 
birth. The foal serum iodine levels were 14.1-fold higher than mare levels indicating active 
transplacental transfer from the mare during late pregnancy. The observed median levels of 
serum iodine in foals at day 0 were very high 268.5 ± 8.6 µg/L and then decreased over time, 
reaching a median of 70 ± 23 µg/L ten days later. It is worth mentioning that the high iodine 
level in foal’s serum at foaling day reported in the present study may reflect some intestinal 
absorption as all blood samples were taken after the foals were bottle fed with colostrum, 
nevertheless, iodine levels in colostrum samples had a wide variability, ranging from 35 to 383 
µg/L. The foal iodine levels were greater than 200 µg/L, with the exception of one foal with 179 
µg/L, despite the lower iodine concentrations in their respective mare’s colostrum. Iodine 
transfer through the mammary gland into colostrum is significant and may have caused an 
increase in serum iodine levels in foals, but the fact that the thyroid hormone levels are very high 
at birth reflects that the foal received transplacental iodine before parturition. Austin et al (1980) 
demonstrated that iodine levels in pre sucking calves were high suggesting transplacental transfer 




rapid fall and individual variability in the serum iodine levels from day 0 to day 10. The high 
iodine levels in the neonatal period mirrored the high foal serum TT4 and TT3 levels, which are 
shown in Figure 4.3. This is consistent with the rapid fetal growth and final organ maturation and 
metabolic capacity needed for extra uterine life. Foal serum iodine concentrations were highly 
correlated with TT4 levels at both time points, and this outcome was expected as TT4 is the main 
source of organic iodine [24]. Our results in foals are similar to Austin et al. (1980) who studied 
neonatal dairy calves. They reported the serum iodine levels in one-day old calves from cows 
receiving two different levels of dietary iodine (0.6 µg and 4.6 µg / kg DM, respectively). Calves 
from cows fed the lower iodine diet had an average mean serum iodine level of 214 ± 16 µg/L, 
whereas, calves from the high iodine diet had an average of 960 ± 87 µg/L iodine. Both groups 
of calves had a marked decline in serum iodine levels over an eight-day period [1,40], showing 
that iodine supplementation during pregnancy had a direct effect on the calf’s serum iodine 
levels, and that high serum iodine levels are present in apparently healthy growing calves.  Both 
healthy calves and foals have high iodine levels that decrease over time in the neonatal period 
compared to their dams [1,40]. 
There is very little published information on serum iodine levels in mares. The observed 
median ± SE serum iodine levels in mares (19 µg/L ± 3.4) were similar to the results of Japanese 
investigators who reported lower mean serum iodine (17.5 µg/L) levels in horses in an 
environment with low soil iodine compared to values from horses in other areas of the country 
with high soil iodine (22.5 µg/L), or where horses in a high soil iodine region had been 
supplemented with seaweed (29.33 µg/L) [8].  
Using the serum iodine reference ranges from Puls (1994), six out of the ten mares in this 
study were classified as marginal in serum iodine [41]. Our estimated iodine intake was based on 
feed iodine values reported by Geor et al., (2013) for forage and grain, and the information from 
the mare owner on the quantities of mineral fed [160]. We reported under the circumstances of 
this study that the mare’s total dietary intake, which was estimated as 39 mg, of which 35.8 mg 
came from supplements, was insufficient for the demands of pregnancy based on the serum 
iodine levels in the mares. The investigators relied on information supplied from the owner, who 
had a regular schedule for feeding, and who knew the weights of the mineral quantities fed. It is 




intake of the mares was voluntary and not controlled, and the amount of the mineral that may 
have been wasted could not be directly accounted for. The recommended range of iodine for 
mares has been reported to be between five to ten micrograms per kilogram body weight [161]. 
The calculation for iodine using this range would yield from 3.4 mg – 6.8 mg total daily iodine 
intake required for the draft mares in this study. There was no evidence of iodine toxicity, such 
as goiter formation, in the mares and foals in this study [8]. Based on the total amount of iodine 
(mg/kg) provided the mares received 7.2 times more than the recommended daily intake by the 
National Research Council for a 680 kg horse during pregnancy, (5.44 mg of iodine per day) 
[161] and 5.7 times more than the upper iodine intake recommended (6.8 mg per day) [161]. All 
mares in this study foaled apparently healthy foals and iodine levels in colostrum and milk were 
considered adequate or higher based on Puls (1994), suggesting that despite marginal levels of 
iodine in serum and high mineral supplementation levels, maternal iodine transfer to the fetus 
was adequate during pregnancy and early lactation [41]. Puls (1994) has no reference levels 
listed for colostrum and reports milk iodine levels > 50 µg/L as toxic. The high levels we 
measured are likely within the normal physiologic range for milk and caution should be 
exercised when interpreting iodine levels in the early post-partum period. The higher end of the 
reference range for milk or colostrum iodine may require adjustment.  
The mares in this study had access to a loose salt / mineral mix and a salt block. Schryver 
et al. (1987) reported a wide range of voluntary daily salt intake from salt blocks, with the upper 
limit being of 0.35 g salt per kilogram body weight without having detrimental effects on the 
horse’s health [162]. These authors reported a mean voluntary intake of 55 g per day from salt 
blocks for 400 – 550 kg horses. Applying the 0.35 g/kg salt consumption per day for a 680 kg 
mare, the maximum voluntary consumption would be 238 grams of salt per day. Other authors 
however reported a range of 14 – 19 g of block salt per day from salt blocks in athletic horses, 
with consumption of salt affected by feeding frequency [76]. In the present study based on 
calculations using the amount of block salt fed the mares would have on the average consumed 
77 g of block salt per day, 9.2 g of salt in the mineral mix and 115.5 g of the iodized salt which 
totals 201.7 g, which is close to the 0.35 g/kg salt voluntary intake reported (238 g). The 




supplement may have resulted in a relatively high intake per day per mare and thus a high iodine 
intake because horses will consume more loose salt than salt from a block [68]. 
Based on mare’s serum iodine data it is possible that pregnant mares under these 
conditions have a higher demand for iodine than has been reported [162]. In many species, 
iodine requirements double during pregnancy. The marginal serum iodine levels in the group 
may be explained by individual mares not consuming sufficient amounts of the supplements, 
excessive amounts of wastage, high excretion rates, or other dietary components which may have 
influenced iodine uptake [66].  Other dietary factors that may impact serum and milk iodine 
levels include the ingestion of feeds containing goitrogenic compounds including wild or 
cultivated plants in the Brassica family such as canola, rapeseed, and mustard, or compounds 
such as nitrates in feed or water [66]. These dietary factors would have to be considered when 
interpreting serum and milk levels of iodine in most species, and no attempt was made to control 
for these in this study [66].   
In the present study, the median iodine level in mare colostrum was 165 µg/L with a 
minimum and maximum range of 24 and 383 µg/L, respectively. Figure 1 shows a decrease by 
day 10 in all mares to approximately half of the initial value, with a median value in mare milk 
of 48 µg/L and a minimum and maximum range of 15 µg/L and 153 µg/L respectively, at 10 
days post foaling. This is similar to the data reported by Navrátilová et al. (2019) concerning 
iodine levels in mare’s milk in the first month of lactation as 120 µg/L [42]. We concluded that 
the mare’s mammary tissue was able to concentrate iodine in colostrum and milk and this would 
be a source of iodine for foals. We note that milk production is variable among mares, which can 
contribute significantly to the variation seen in milk iodine levels.  Other authors have reported a 
decrease in other mineral levels during the transition from equine colostrum to milk [163,164]. 
Navrátilová et al. (2019) report that mare milk iodine level decline in the first 6 months post-
partum from 120 µg/L to 28 µg/L [42]. Kavazis et al. (2002) and Csapo-Kiss et al. (1995) 
reported higher copper (Cu) and zinc (Zn) levels in colostrum compared to milk at 28 days post 
foaling, with an average of 1,110 µg/L versus 350 µg/L for Cu and 2,880 µg/L versus 174 µg/L 
for Zn [163,164]. Similarly, Fantuz et al. (2013) reported a mean level of iodine, Zn and Cu in 
donkey milk samples taken from 46 to 142 days post foaling of 74.9 µg/L, 2,246.8 µg/L and 97.6 




milk, suggesting that the mammary tissue of jennies was regulating the transfer and 
concentration of these trace minerals into milk [46]. The data from the jennies is similar to the 
pattern observed in the present study with mares, in which colostrum samples had higher levels 
of iodine compared to serum samples, and milk [46]. The jennies had higher milk iodine levels 
than the mares in this study [46]. This may be attributed to the level of iodine in the environment 
and the rate of supplementation in the diet. In dairy cows a 75% increase in iodine 
supplementation from 0.5 mg/kg to 2.0 mg/kg of diet DM increased iodine levels in milk within 
22 hours, going from an average of 416 to 602 µg/L; a 45% increase [48], whereas an 80% 
increase in iodine supplementation from 0.82 mg/kg to 4.0 mg/kg in jennies resulted in an 25% 
increase in iodine levels in milk compared to the control group whose iodine intake was 0.82 
mg/kg [46]. This data indicates in equids the mammary gland is able to respond efficiently to 
dietary variations in iodine during late pregnancy and lactation similar to dairy cows. The dietary 
level of iodine (4 mg/kg) in the study of Fantuz et al. (2013) was higher than the amount of 
iodine (2.4 mg/kg DM) estimated to be consumed by the mares in the present study [46]. 
Thyroid hormones and iodine are essential for fetal maturation before parturition and for 
neonatal adaptation [11,24]. Dramatic pre-partum increases in cortisol and TT3 in fetal 
circulation are reported to be essential for extrauterine survival, such as lung maturation, 
thermogenesis, hepatic gluconeogenesis and nervous system development [11,24,121]. Similar to 
other authors we report high levels of TT4 and TT3 in the post-natal period [24]. The median 
serum TT4 level in the foal was 65.9 times higher than the mare level on day 0. Both TT4 and 
TT3 rapidly declined from day 0 to day 10 in the foals, with a proportionately greater decline in 
TT4 (17.6-fold) than TT3 (2.6-fold).  We report a positive correlation with foal serum iodine and 
TT4 in healthy foals. It has been reported that deficiencies in thyroid function caused by either 
excessive or inadequate amounts of iodine or due to exposure to goitrogens during the critical 
phases of fetal growth and maturation, have serious negative consequences for the foal, and have 
adverse effects on the foal’s future health and performance [24,165]. Imbalances in dietary 
iodine have been reported to cause goiter in foal [108,166–168]. We anticipate that these adverse 
maternal and fetal exposures to iodine would alter foal serum thyroid hormone concentrations, 
serum iodine levels, colostrum and milk iodine levels and the foal TT4/TT3 ratio, but this 




Table 4.1. Mineral and vitamin composition of the vitamin and mineral supplement.  
 
 
Mineral and vitamin composition of loose horse mineral supplementation (20 kg) 
 
Ingredient Amount per kilogram Ingredient Amount per kilogram 
Calcium 12.0% Vitamin A 600,000 IU/kg 
Phosphorus 8.0% Vitamin D3 40,000 IU/kg 
Magnesium 1.6% Vitamin E 2,000 IU/kg 
Salt 8.0% Vitamin K 15 mg/kg 
Sodium 3.2% Vitamin B12 200 mcg/kg 
Potassium 4.0% Biotin 40 mg/kg 
Iodine  40 mg/kg Riboflavin 400 mg/kg 
Iron 40 mg/kg Thiamine 350 mg/kg 
Copper 700 mg/kg Niacin 1,600 mg/kg 
Manganese 1,900 mg/kg Pantothenate  200 mg/kg 
Zinc 4,000 mg/kg Pyridoxine 20 mg/kg 
Cobalt 27 mg/kg Folic Acid 58 mg/kg 
Fluorine 1000 mg/kg Choline Chloride 1,000 mg/kg 






























Table 4.2. Mare and or foal basal serum levels of TT4, TT3 (nmol/L) and iodine µg/L [median ± 
median standard error (quartiles)] at the day of foaling (day 0) and day 10 post-foaling. Iodine 









TT4 nmol/L Day 0 Day 10 
Foal 1225 ± 47.8 (757.7, 1292.7) 69.6 ± 20.4 (60, 98.1) 
Mare 18.6 ± 0.6 (15, 21.7)  
   
TT3 nmol/L   
Foal 14.2 ± 1.1 (11, 21) 5.4 ± 0.3 (4.6, 5.9) 
Mare 0.98 ± 0.04 (0.90, 1.40)  
   
TT3/TT4 ratio   
Foal 85.9 ± 8.5 (46.9, 103.2) 15.4 ± 1.6 (13.4, 16.5) 
Mare  16.1 ± 0.6 (14.4, 20.1)  
   
Serum Iodine µg/L   
Foal 268.5 ± 7.5 (258,293.5) 70 ± 3.6 (54.7, 87.5) 
Mare 19 ± 0.5 (17, 22)  
   
Colostrum Iodine µg/L  165 ± 15.1 (73.5, 238.5)  






Figure 4.1.  Iodine levels (µg/L) in paired colostrum and milk samples at foaling (day 0) and day 




















Figure 4.2. Serum iodine levels (µg/L) in paired samples obtained from ten foals on the day of 
















Figure 4.3. Serum total thyroxine levels (TT4) (nmol/L) in paired samples from ten foals on the 





















CHAPTER 5: GENERAL DISCUSSION 
 
The negative effects of GSL on thyroid hormone levels and iodine metabolism have been 
described in dairy cows and other domestic species, in which adequate levels of iodine in milk 
products need to be present to meet the requirements for human consumption [47, 66, 83]. 
Nevertheless, to the author’s knowledge there are no previous reports on the effect of 
glucosinolates on thyroid function and iodine levels in horses at any age and physiologic state; 
there is also a lack of robust information on normal iodine levels in mares and foals in different 
body fluids and secretions despite the prevalence of congenital hypothyroidism dysmaturity 
syndrome (CHDS) in foals in Western Canada, where Brassica family plants are widely 
cultivated, mustard family weeds are abundant and iodine concentration in the soil is inadequate 
[65, 134, 135, 140]. Iodine and thyroid hormone levels are linked as iodine is necessary for 
thyroid hormone synthesis [51, 65]. Adequate levels of thyroid hormone concentrations are 
essential for normal fetal development, especially growth and maturation of the musculoskeletal 
system in the second and third trimester of gestation [59]. Maternal thyroid hormones are 
reported to be unable to reach the fetal circulation from the second trimester of pregnancy to 
term in species with an epitheliochorial placenta such as the horse and ruminants, but the fetal 
hypothalamic-hypophyseal-thyroid axis is active by this stage and stimulates the synthesis of 
fetal thyroid hormones [11, 55]. Nevertheless, iodine transfer from maternal to fetal circulation is 
essential for normal fetal thyroid hormone synthesis but also for adequate gas exchange, 
thermogenesis and hepatic gluconeogenesis in the neonatal period [11]. In order to maintain 
adequate fetal thyroid hormone synthesis, iodine transfer from maternal to fetal circulation is 
essential, thus, maternal iodine deficiency caused by nutritional deficiency and/or goitrogenic 
compounds that compete with iodine transport into the thyroid gland can lead to thyroid 
dysfunction in the fetus [40, 44]. In infants, it is well documented that hypothyroidism during 
pregnancy severely also affects brain and cognitive development of infants [28].  
A syndrome characterized by prolonged gestational length, moderate to severe 
musculoskeletal deformities such as contracted tendons, failure of tarsal and/or carpal 
ossification, prognathia, signs of dysmaturity and goiter called congenital hypothyroidism 
dysmaturity syndrome in foals (CHDS) has been described in Western Canada since the late 




presentation of CHDS and the pathogenesis is not completely understood but lack of trace 
mineral supplementation, feeding green feed, and consumption of plants containing GSL during 
pregnancy have been reported. Glucosinolates (GSL), which are commonly found in 
Brassicaceae family plants, have been reported to have negative effects on animal health. Major 
GSL metabolites such as isothiocyanates, thiocyanates and oxazolidinethione disrupt iodine 
availability to the thyroid, thus causing thyroid dysfunction. The effect of GSL has been 
described in other domestic animals but there is little information in horses. Research in dairy 
cows receiving rapeseed meal for example, showed that the cow’s iodide concentrations in milk 
decreased while the levels of thiocyanate increased. 
We aimed to characterize iodine levels in serum, colostrum and milk samples along with 
thyroid hormone concentrations from mare and foal pairs at foaling date and ten days later, as 
well as the effects of the GSL sinigrin in combination with a low iodine supplemented diet on 
thyroid hormone and iodine concentrations in non-pregnant mares. The idea was to determine the 
normal iodine reference range in mares and foals from different body fluids and recreate the 
conditions that were reported to be risk factors for CHDS in foals to determine if there is a 
negative effect on thyroid hormone concentrations and iodine levels in blood from mares 
exposed to the mustard meal. 
In the first study (chapter 3), we partially accepted our hypothesis that the combination of 
sinigrin and a low iodine diet altered thyroid hormone concentrations. It was clear that serum 
iodine increased in the Control group mares and decreased in the GSL mare groups by week 12. 
The experimental design did not allow us to clearly determine which factor (sinigrin, or low 
iodine) or if both were responsible for the thyroid response to treatment. The study was started in 
late summer and concluded in late fall just before the winter solstice. The weather was extremely 
cold in the month of November during the trial and at this latitude daylight was decreasing 
rapidly. The data showed a marked response to TRH in terms of thyroid hormone secretion in the 
Control mares and this effect was absent in the GSL mares. At week 12 the response to the TRH 
was similar in the GSL mares to their week zero responses. The question was whether the 
marked response to TRH in the Control group mares was due to a seasonal effect. As there were 
no studies performed under similar management conditions, or with similar climatic and 
geographic factors, it was unclear whether the enhanced response to TRH in the Control group 




diet with a seasonal effect, or conversely whether there was a suppression of the response to 
TRH in the GSL groups mares at week 12. The cause of the suppression in the TRH response in 
the GSL groups, if it was present, may be related to the effects of the GSL diet, such as through 
the depletion of stored iodine in the thyroid or other factors. It was apparent from many studies 
that the effects of GSL may be diminished by supplementation with iodine [48,79,138,150,169–
171]. To the authors’ knowledge, the effect of iodine supplementation on thyroid responsiveness 
to TRH in horses has not been addressed; however, studies performed in euthyroid human 
patients stated that there is a normal transient effect of a high level of iodine supplementation in 
the diet, in which TT4 concentrations decrease, with a mild increase in TSH levels [157]. This is 
not compatible with our findings as Control group mares did not show a decrease in basal TT4, 
and TSH levels were within normal limits. The lack of change in TSH was also of interest 
because the TSH levels were similar between Control and GSL groups in terms of response to 
TRH administration, however the thyroid response in terms of the post – TRH release of thyroid 
hormone and conversion from T4 to T3 were different in Control versus GSL groups. The 
response to TRH is not fully dependent on the thyroid hormone stores within the gland [19]. In 
the mare it has not been determined what portion of the TRH response is due to the release of the 
stored hormone in the thyroid gland and what proportion is due to the effects of TSH on the 
changes in peripheral conversion of T4 to T3 [172,173]. The post TRH peak level of T3 occurs 
at 2 hours, while the peak in T4 occurs at 4 hours [174]. The effect on the thyroid response to 
TRH could be explained by: changes in thyroid hormone receptor expression or binding; effects 
of GSL on iodide transport and depletion of thyroid hormone stores; changes in peripheral 
conversion by deiodinases; or other factors. Some studies in people have reported that thyroid 
health may be affected by GSL and dietary iodine without altering basal TSH levels [85,175]. 
Further studies need to be performed to determine why the response to TRH in terms of thyroid 
hormone concentrations was different while TSH levels were similar in the experimental groups.  
Regarding serum iodine levels, there was a noticeable increase in the Control group, 
whereas GSL groups decreased their levels by week 12 compared to week 0. The decrease in 
serum iodine would be an expected outcome of a 12-week dietary sinigrin exposure. It was our 
opinion that the change in serum iodine was unlikely to be caused by the low iodine diet alone; 
however, the experimental design does not allow us to draw a conclusion in this regard. Because 




trace mineral supplementation and exposure to possible goitrogens, we avoided supplementation 
with additional iodine in the GSL groups [6,176]. Eisenbrand and Gelbke (2016) reported that 
sodium iodide symporter inhibitors may decrease thyroid iodine by 20% [99]. It has been 
reported that supplementation with iodine has been shown to counteract the effects of GSL [50]. 
It is worth mentioning that the lack of a GSL group with iodine supplementation, or a control 
group without iodine supplementation along with the measurement of iodine and creatinine 
levels in urine would have strengthened the study. Without this information there are still 
knowledge gaps in the understanding of the effect of GSL on iodine levels in horses. This was an 
unavoidable consequence of the financial limitations of the study. Furthermore, there is little 
information regarding the tolerance and palatability of sinigrin, which is metabolized to 
isothiocyanates, and the negative effects may have been underestimated as the oriental mustard 
powder is intended to be used for human consumption, thus, GSL detoxification may have been 
performed, or the processing method may have decreased the GSL content.  
It was beyond the scope of this study to measure the metabolites of sinigrin in the mare’s 
serum. Based on the present study, a concentration of 20 – 35 mmol/day of sinigrin was 
adequately tolerated by the Low and High GSL groups, respectively, until the end of the feeding 
trial and there was no change in feed consumption. We note that not all mares would consume 
the mustard as horses are selective eaters and this prevented full randomization of the mares into 
groups. Lastly the numbers are relatively small in the study and the data must be viewed with 
this in mind.  
The results from the third chapter indicates that the GSL sinigrin is able to compete with 
iodine uptake by the thyroid gland in the non-pregnant mare, nevertheless, there is still limited 
and inconsistent information regarding normal serum and milk iodine levels in adult mares, and 
there is no reference range reported in foals. Since iodine is an essential trace mineral for thyroid 
hormone synthesis and the lack of information can interfere with an accurate interpretation of the 
results, the goal of the second study (chapter 4) was to characterize the serum iodine values in 
postpartum mare foal pairs, and levels of iodine in milk and colostrum. The results showed clear 
evidence of active transplacental transfer of iodine from the mare to the fetus during late 
pregnancy, as iodine levels in serum samples from neonatal foals taken between one to four 
hours post-foaling revealed a 14.1-fold higher level than the mare. Even though pre suckling 




iodine concentrations were more highly correlated with levels in the feed than in colostrum [49]. 
We have evaluated a few samples from foals before and after colostral ingestion and the high 
serum iodine level is present before suckling (data not shown) in agreement with this finding. As 
the main source of organic iodine is thyroid hormone the iodine levels in the foals were 
correlated and consistent with their serum iodine levels.    
Furthermore, under the circumstances of this study and based on specific information 
supplied from the owners, the estimated voluntary iodine intake per day / mare was of 39 mg, of 
which 35.8 mg came from supplements. What was noteworthy was that this level of iodine 
supplementation was insufficient for the demands of pregnancy based on the serum iodine levels 
in the mares, as six out of ten mares had marginal serum iodine levels despite iodine 
supplementation through the entire pregnancy. A limitation of this field study was that the 
mineral intake of the individual mares was not controlled and may have been uneven between 
mares. Nonetheless it is worth mentioning that the recommended range of iodine intake for 
mares is between five to ten micrograms per kilogram body weight, thus, a calculation using this 
range would mean that the total daily iodine intake would range from 3.4 mg – 6.8 mg. The 
mares’ intake was therefore much higher than the recommended level however, there was no 
evidence of iodine toxicity, such as goiter formation, in the mares and foals in this study [177]. 
This may be interpreted to mean that the demands of late pregnancy for iodine are much higher 
than the reported NRC recommendations. It would have been optimal if 24-hour urine creatinine 
and iodine levels could have been assessed to determine if iodine metabolism and excretion was 
within normal limits. Also, because this was a field study, there was no attempt to control for 
factors such as antithyroid compounds present in the environment and feed, such as nitrate or 
GSL. This may explain why iodine intake levels were high, yet 6/10 mares had marginal serum 
iodine levels as these substances interfere with iodine uptake and iodine is excreted in the urine. 
While the mares in this study showed no evidence of toxicity, it has been reported that iodine 
levels that induce toxicity are often in excess of 10 times higher than the recommended dietary 
level [177]. In humans it has been reported that women in Japan may have 10 - 25 times the 
recommended amount of iodine in their diet, as it is customary to consume seaweed which is an 
iodine rich food, and do not show signs of toxicity [178]. It may be that different species adopt to 
their environmental circumstances of iodine excess or deficiency, or that the range of tolerance is 




On the other hand, Puls (1994) has no reference levels listed for iodine concentrations in 
colostrum and milk iodine levels > 50 µg/L are reported to be toxic [41]. We concluded that the 
recommended levels of iodine in milk do not apply to colostrum, as colostrum values are 
significantly higher. Colostrum and milk both have higher iodine levels than serum showing that 
the mammary tissue of the mare is able to concentrate iodide. Navrátilová et al. (2019) provided 
valuable information on the iodine level in milk by month of lactation [42]. The high levels of 
iodine we reported in colostrum and milk samples were from mares that showed no evidence of 
iodine toxicity, suggesting that the higher end of the reference range for milk iodine may require 
adjustment, and a separate range should be provided for colostrum. The mare apparently makes a 
significant investment in the health of her fetus and neonate by supplying her offspring with 
minerals [163]. We concluded that further studies should be performed in mares with known and 
confirmed iodine intakes to create more robust reference ranges for serum, colostrum and milk. 
Iodine is essential for thyroid hormone formation. There is wide recognition of the role of 
thyroid hormones in epigenetic programming in horses [126,179]. Important processes such as 
metabolism, boney development, are controlled by thyroid hormones [180,181]. Thyroid 
hormones and iodine concentrations in foal serum were highest on the foaling date and decreased 
over a ten-day period of time. There was a positive correlation between foal serum iodine and 
TT4 in healthy foals, indicating the important role of iodine in the highly active thyroid gland 
during the neonatal period. This high level of thyroid hormone has been reported to be critical 
for neonatal adaption [11]. This study therefore makes important contributions in establishing the 




CHAPTER 6: CONCLUSIONS AND FUTURE STUDIES 
 
The long term objective of this research was to have a better understanding of the impacts 
of a low iodine supplemented diet combined with GSL exposure in non-pregnant mares with a 
view towards utilizing the data for a subsequent study in pregnant mares, where the impact on 
fetal and neonatal development and maturation would be examined. Low dietary iodine and 
goitrogenic GSL are considered to be risk factors for mares that deliver foals with congenital 
hypothyroidism dysmaturity syndrome. Goitrogenic GSL have been confirmed to affect thyroid 
function and fetal musculoskeletal development in other farm animals; however, the effect of 
GSL in combination with inadequate mineral intake, such as iodine, in horses is unknown. There 
is generally a reluctance to fund studies that propose to euthanize horses and foals and this limits 
the capacity to evaluate detailed changes in musculoskeletal tissues or thyroid iodine content.  
Sinigrin is a GSL that is not as highly goitrogenic as other GSL [66,132,182]. The 
metabolites of singrin such as nitriles and allyl-isothiocyantes are less potent than other GSL 
whose metabolites include isothiocyanates (progoitrin) [169,183–185]. Sinigrin was chosen 
because it was available in a convenient oriental mustard powder. The production of a crushed 
mustard seed meal for the study was logistically problematic because of the many regulatory 
barriers to having a GSL containing feed prepared. There are also significant production costs 
associated with cleaning the crushing and milling equipment to remove the GSL from mustard 
seeds.  
We found the combination of low dietary iodine and sinigrin reduced serum iodine levels 
over time in the mares. There is much left to discover about the effects of GSL in horses. 
Cymbaluk (1991) and Oliviera et al. (2001) reported no deleterious effects of feeding canola 
meal to growing horses for a few months and the mares in our study did not show adverse health 
outcomes [141,142]. The sensitivity of the pregnant mare and her fetus to GSL remains to be 
determined. As there was a lack of laboratory capacity in measuring iodine for a prolonged 
period there is a gap in our understanding regarding the effects of GSL in horses and their 
interactions with other minerals such as selenium and substances such as nitrates and nitrites. In 
addition, the authors note that robust reference limits for serum, colostrum and milk iodine in 
horses are lacking. For that reason, reference values for iodine concentrations in mare and foal 




diagnose and study problems such as iodine deficiency disorders in the future. This thesis 
constitutes a first approach to these goals.  
 
Based on the results of the presented studies we concluded that: 
• Based on the palatability trial, there was a wide variability in the willingness of the mares to 
consume the mustard meal oat mixture; approximately 24% of the mares fully tolerated the 
bitter taste of the sinigrin, and another 24% partially tolerated the taste, suggesting that under 
natural conditions some mares may consume more than others of this type of GSL. Mares 
that consume this type of GSL would be more exposed to goitrogens than other mares.  
• The effect of feeding a diet containing sinigrin at a concentration of 20 – 35 mmol per day in 
combination with a low iodine supplemented diet to non-pregnant mares decreased serum 
iodine concentrations by week 12, based on the significant decrease in iodine concentrations 
in the GSL groups. This was more evident in the High GSL group compared to the Control 
group. The GSL sinigrin, whose secondary metabolite includes allyl-isothiocyanate, may 
have prevented iodine uptake by the thyroid gland. Consumption of sinigrin would be 
expected to result in increased renal excretion of iodine resulting in lower iodine serum 
concentrations over time.   
• Feeding sinigrin for a 12-week period impaired TT4 TRH responses by week 12, with no 
effect on TT3 and TSH response in the GSL groups. Therefore, primary hypothyroidism was 
not present, as the TSH response was adequate between groups. Impaired and/or low TT4 
TRH response has been reported in early stages of hypothyroidism in dogs, suggesting that in 
the present study, a three-month trial was not long enough to cause more pronounced effects 
on THs levels.  
• The effect of sinigrin along with a low iodine supplemented diet did not have a negative 
impact on body weight and overall health. Nevertheless, the study was conducted in non-
pregnant adult mares, in which thyroid function is less critical compared to thyroid function 
in pregnant mares or a developing fetus.  
• Neonatal foals have higher serum iodine levels than mares, and serum iodine is positively 
correlated with foal TT4 concentrations in the first week of life. 
• Foal serum iodine, TT4 and TT3 concentrations decrease rapidly from day 0 to day 10 in the 




• Equine mammary tissue is able to concentrate iodine beyond plasma levels, making 
colostrum and milk a significant source of iodine for foals, similar to other trace minerals. 
• Mare colostrum contains higher amounts of iodine compared to mare milk and may be a 
source of iodine for foals. 
• The estimated voluntary iodine intake of the draft mares exceeded approximately 7 times the 
NRC recommended iodine intake in the mares in the field study without signs of toxicity. 
This indicated that the requirements for iodine during pregnancy should be determined using 
controlled nutritional trials.  
 
The limitations of the presented studies are: 
• The group sizes were small in both studies. 
• Serum iodine was measured, and urine iodine / creatinine levels were not determined. A 
comparison between serum and urine iodine concentrations indexed to creatinine are 
recommended in future studies to have a better understanding of iodine uptake. 
• The time of year or the inclusion of iodine supplementation to the control group may have 
influenced the Control mare’s response to TRH. We suggest that lack of TT4 response to 
TRH in the High GSL group compared to the Control group may have been due to: 
differences in iodine supplementation, GSL effects, seasonal factors or a combination of 
these factors. There were unfortunately insufficient research funds to include a Control low 
iodine group, or a high GSL group with iodine supplementation. 
• The field study of serum, colostrum, milk iodine and thyroid hormone concentrations in 
mares and foals is limited because it is observational data.   
• Individual mare mineral/loose iodine mixture intake was not determined, and the hay and 
oats were not analysed for iodine content. 
• The presence of other environmental (example perchlorates) or feed (example nitrates, GSL) 
antithyroid agents was not investigated in the field study.  
• Iodine levels in pre and post-suckle foals were not determined. Therefore, there is still the 
question of whether high iodine serum levels seen in day 0 foals resulted partially from 







Further research is needed to determine:  
• The lowest amount of GSL that when fed with a low iodine diet suppresses serum iodine 
concentrations;  
• The effects of various different GSL on thyroid hormone and iodine concentrations and the 
response to TRH;  
• The concentration of dietary iodine required to protect mares from the effects of GSL. 
• The effects of a low iodine supplemented diet along with goitrogenic GSL on pregnant mares 
and their newborn foals.  
• A determination if there is a seasonal response to TRH in mares in northern latititudes 
 
In addition, future work is required to better determine reference limits for serum, colostrum and 
milk iodine in mares with known and confirmed iodine intakes 
• The pre suckle and post suckle iodine level in neonates based on observational studies in 
which serum and milk iodine concentrations of pregnant and lactating mares are examined in 
light of confirmed iodine intakes.  
• Studies comparing 24-hour urine creatinine iodine ratios to spot urine creatinine iodine 
determinations in horses with known and confirmed iodine intakes to determine if a spot 
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